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ABSTRACT 
Inhalation of ultrafine and ambient particles in the air triggers a response in the innate immune 
system of the airways. This thesis explores measures to reduce exposure to organic dust, to 
dampen the adverse immune effects of chronic organic swine dust exposure and develop a 
refined in vitro bronchial mucosa model to reduce in vivo toxicity testing on humans and 
animals. 
In Paper I, the aim was to reduce particulate matter exposure by installing particle separators 
in swine buildings and to explore the respiratory effects in healthy subjects after acute exposure. 
Exposure measurements including organic dust including endotoxins in both swine building 
environments (with and without particle separation) were performed and the particle separators 
reduced mainly particles sized 0.3-0.5 µm. The adverse acute symptoms like headache and 
increased body temperature in the volunteers were reduced when exposed to the particle 
separated swine building environment compared to the conventional swine building 
environment. The particle separators reduced the pro-inflammatory responses (IL-6 and 
CXCL8) in the upper respiratory tract compared to the conventional swine building 
environment. 
In Paper II, the aim was to investigate the host innate immune response in vivo in chronically 
organic dust exposed swine farmers after short-term glucocorticosteriods therapy. Swine 
farmers inhaled budesonide for two weeks which increased their release of soluble TLR2 in 
the airways. Systemic effects included increased number of circulating leucocytes and TLR4 
expression on lymphocytes, and decreased cytotoxic T-cell production of IL-13 and IL-4. 
The second aim of Paper II was to elucidate the cellular immune response of alveolar 
macrophages from chronically exposed swine farmers to ex vivo co-stimulation of 
glucocorticosteroids and TLR ligands. In alveolar macrophages, mRNA TLR2 expression 
increased and CXCL8 decreased after ex vivo co-stimulation with LPS/peptidoglycan/TNF-α 
and budesonide. The mRNA expression of CD14, IL-13 and GPx in alveolar macrophages 
increased after the in vivo steroid treatment of swine farmers. In all, this study showed that 
inhalation of a glucocorticosteroid strengthens the immune defense pathways in subjects with 
occupational chronic exposure to organic dust. 
In Paper III, the aim was to develop an organotypic in vitro exposure system; combining 
bronchial models with XposeALI® for exposure of nano-sized palladium. Here we established 
a viable and robust in vitro bronchial mucosa co-culture model using human primary bronchial 
epithelial cells and a fibroblast cell line showing in vivo characteristics. By stimulation with 
IL-13, the model differentiated into a chronic bronchitis-like model. It was successfully 
combined with the advanced aerosol exposure system PreciseInhaleTM and the in vitro module 
XposeALI® and exposed to palladium nanoparticles, which induced inflammatory responses 
in the 3D models. 
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INTRODUCTION 
Particulate matter - particles that matter 
Or do they? 
In this thesis we are trying to shed light on how ultrafine and ambient particles, matter to 
humans. 
Inhalation of particles affect the human immune system. But is it necessarily bad? Are there 
adverse effect? 
Some people are allergic to agents they inhale; like pollen, house mite dust or dander from cat 
and dog. These cases are generally easy to spot, diagnose, and even treat. But the particles that 
don’t cause these acute, obvious effects – are they also hazardous to human health? Yes and 
no. There are many factors that need to be considered.  It is not only the composition of the 
particle itself, but also the size, shape and dose that matters. Does inhalation of particles have 
any immunological effects in the human respiratory tract and how are these effects measured? 
Elucidation of these questions is the reason why you should continue reading. 
PARTICLES 
Characteristics and hazard 
Particulate matter (PM) air pollution is an important risk factor for adverse health effects. It 
consists of agglomerates of solid and liquid particles suspended in air and vary in origin and 
composition. Size is an important parameter to understand the fate for settling on surfaces and 
fate primarily in the respiratory system but also the rest of the body. The largest measured PM 
fraction, identified as PM10 are coarse particles with a median aerodynamic diameter (MAD) 
≤10 µm. PM4 is often used as a cut-off for respirable particles, however it is the fraction PM2.5 
(MAD≤2.5 µm) that has and continues to get increased regulatory attention. 
WHO global air quality guideline limits for PM2.5 and PM10 are: 10 µg/m
3 for the annual 
average (25 µg/m3 for the 24-hour mean, not to be exceeded for more than 3 days/year) and 20 
μg/m3 for the annual average (50 μg/m3 for the 24-hour mean), respectively [1]. 
Recent advances in nanotechnology has led to an increase in the manufacture and use of 
nanoparticles which are engineered to be <100 nm in one dimension. The unique properties 
has enabled them to be used in a variety of industrial and consumer products, such as sun-
creams, paints, clothes, cosmetics and spray cleaners. Due to their use in consumer products 
and media coverage, the public have become more aware of nanoparticles and the possible 
presence in their daily life. To better understand the volumes in use registration of nanoparticles 
is currently mandatory in Belgium, France, Denmark, Norway and Sweden. Also in the 
environment presence of micro- and nanoplastics are an emerging topic of concern. The interest 
of nanoparticles from authorities and researchers is linked to scarce knowledge of human 
exposure and toxicity of these small particles. Yet, human exposure to small airborne particles 
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is not new. Bacteria and viruses, forest fires, volcanic activities and strong winds over sea or 
dessert are all natural contributors to ambient particles called ultrafine particles (<100 nm). 
Not only natural, but also anthropogenic sources such as combustion engines, frying and 
grilling of food and welding fumes contribute to human inhalation of ultrafine particles [2]. 
Notably, size-wise the diameter of the ultrafine particles is more than 100 times smaller than 
the diameter of a PM10 particle. 
Biological effects of particle exposure 
The possible hazards of nano- and ultrafine particles are often linked to their large and reactive 
surface area [3]. For understanding the toxicity including the fate of the particles in air and the 
respiratory tract, physical characterization of the particles is essential. Their ability to form 
agglomerates from primary particles, into larger ultrafine to microparticles, secondary particles 
influences the hazard potential. 
Exposure to ambient particulate matter and its association to cardiovascular morbidity/ 
mortality is well-established [4, 5] likely due to the induced systemic inflammatory response 
[6, 7]. The exposure also correlated to the hospital admissions of asthma and COPD [8, 9]. The 
World Health Organization IARC reviewed existing carcinogenicity data and classified both 
outdoor air pollution and particulate matter in outdoor air pollution as carcinogenic to humans 
due to sufficient evidence in humans. The group claims that the agents “are associated with 
increases in genetic damage that have been shown to be predictive of cancer in humans. 
Moreover, exposure to outdoor air pollution can promote cancer progression via oxidative 
stress, responses to oxidative stress, and sustained inflammation” [10]. 
Occupational exposure 
Occupational exposure to particles and dust in general have long focused on quantity rather 
than quality. Occupational hygienist have measured the total inhalable dust sized <100 µm, 
which is the fraction of airborne materials that enters the nose and mouth during breathing or 
respirable dust which is the fraction sized <10 µm, that could reach the small airways and 
alveoli where the gas exchange takes place. With increased focus on reducing the occupational 
exposure to dust combined with improved analytical techniques and advances in inhalation 
toxicology it has become evident that the size of particles is of importance. For instance, 
recently the Swedish occupational exposure limit of 5 mg/m3 for organic dust changed from 
“total dust” to “inhalable dust” [11]. 
Known occupational exposure to nano- and ultrafine sized dust and particles occurs in groups 
exposed to ambient particles like traffic police and occupational exposure in welders and 
farmers. 
In general, measuring occupational exposure to bioaerosols or organic dust, which contain a 
heterogeneous mixture of agents is challenging [12]. In order to evaluate trends across studies, 
it is important to compare the personal occupational exposure data of the subjects. This is often 
challenging, as crucial information of sampler, airflow of sampler, monitoring duration and 
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tasks that were monitored might be lacking in the reports. This is especially true when 
evaluating endotoxin monitoring and analysis (see Methods). 
Dust in swine farms is characterized by its complex composition of mainly organic material. 
In Swedish swine farms, the total inhalable dust has been detected at 10 mg/m3 and respirable 
dust 0.3 mg/m3 [13] but could be higher (up to 28.5 mg/m3) depending on the level of activity 
of the workers and the pigs. In a large Danish study where exposure in 53 farms was 
investigated, the mean exposure for inhalable dust was 3.4 mg/m3 [14]. It was observed that 
the levels of organic dust were significantly higher in winter than summer which could be 
explained by less use of the ventilation in the winter to save heat and energy in the stables. 
Other important activities known to increase the level of exposure to swine dust is high-
pressure water cleaning of stables and weighing (or other manual handling) of pigs [15]. The 
organic swine dust originates from feces, feed, dander, and contains numerous constituents 
like pro-inflammatory endotoxins and peptidoglycan. Endotoxins, first described more than 
100 years ago, are the heat-stable lipopolysaccarides (LPS) of the outer part of the Gram-
negative bacteria. Endotoxin is generally detected in agricultural settings, cotton production 
and waste processing. Compared to bacteria, endotoxins/LPS are long-lived and can only be 
inactivated though (dry) heating for several hours [16, 17]. National occupational exposure 
limits for endotoxin are not established to date. The Dutch Expert Committee on 
Occupational Safety proposed, based on the acute respiratory effects, a health-based exposure 
limit of 90 EU/m3 in 2010, that has not yet been adopted [18]. 
Nevertheless, dust and endotoxins levels exceed current occupational exposure limits in many 
animal facilities. In 2012, 93% of the swine, poultry, mink and dairy farms in Denmark did not 
meet the suggested Dutch endotoxin OEL of 90 EU/m3. Basinas et al, 2012 examined the day-
to-day exposure of swine and dairy farmers and the influence of working indoor versus outdoor 
[19]. Measurements from 124 personal samplers of farm workers of 26 Danish dairy farms 
showed mean concentrations of dust of 1.0 mg/m3 dust and endotoxin 360 EU/m3 and the 
conclusion was to recommend the use of respirators for certain dust generating work tasks like 
feed handling and bedding (manure) removal [20]. The same research group later investigated 
exposure in Danish livestock facilities reported in 41 studies and among the swine, poultry and 
cattle farms exposure of inhalable dust was 0.8-10.8 mg/m3 and endotoxin exposure was 400-
6600 EU/m3 [21]. Exposure to inhalable dust and endotoxin in swine and poultry farming was 
higher than for cattle, but the peak exposures were often linked to a specific task. Even though 
the highest average exposure to endotoxins were measured for swine farmers, poultry farmers 
had higher dust and endotoxin exposure during the work in the stables. 
Peptidoglycan (PGN) originates from Gram-positive bacteria and is established as an 
important pathogen-associated molecular pattern (PAMP) recognized by TLR2 [22] and 
known to cause inflammation in epithelial and alveolar cells [23]. Peptidoglycan has been 
suggested to be, together with LPS, important in the development of endotoxin tolerance 
observed among swine farmers exposed to organic dust [24].  In vitro, peptidoglycan tolerance 
has been correlated with induced IRAK-M protein [25] but several mechanisms for the 
observed tolerance have been suggested without any scientific consensus [26]. 
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To improve occupational conditions and the environment for growing farm animals different 
measures to reduce exposure have been explored [27], some more successful than others [28]. 
Spraying vegetable oils that form a fog and binds particles was successful, however it is a less 
commonly employed measure nowadays [29, 30]. The efficiency of oil spraying is decreased 
as the humidity increases resulting in only minimal reductions in the endotoxin concentration 
[31]. The use of respiratory protective equipment could be efficient [13, 32, 33], but not to all 
contaminants in the air, e.g. gases [34]. High-pressure water jet cleaning of the stables is known 
to be one of the necessary tasks that causes high exposure of swine dust to farmers [35]. Pre-
cleaning the stable using a robot reduces the inflammatory response systemically as well as in 
the upper and lower airways of healthy volunteers [15]. Such measure would likely have a 
positive health impact in swine farmers, as it would reduce the duration of work in highly 
contaminated stables. A relatively simple, and still successful, intervention tested in order to 
lower the exposure was to send a letter including information on previous exposure 
measurements at the farm accompanied by advice on how to reduce exposure. Thus if farmers 
were aware they were exposed to high concentrations, they were more likely to use some of 
the advices in the letter [36]. 
THE RESPIRATORY SYSTEM 
Breathing – the inhalation of oxygen, the exhalation of carbon dioxide and the exchange of 
gases in the alveoli of the lungs – is crucial for human survival. The inhaled air will pass the 
nose (and mouth), further change directions from horizontal to vertical during the passage 
through the pharynx, larynx, and further down to the lower respiratory tract via the trachea, 
bronchi and bronchioles and finally the alveolar ducts and the alveoli where it then makes the 
reverse journey during exhalation. In the trachea, bronchi, and bronchioles, cilia cover the 
airway epithelium, which is covered with mucus, functioning as a mechanical barrier of the 
body (Figure 1). Mucus produced by goblet cells or submucosal glands traps foreign particles 
and the synchronized beating cilia transport the mucus towards the pharynx to be swallowed. 
The mucociliary clearance is an efficient first line of defense of the respiratory system. The 
second line of defense is the nonspecific innate immune system (see Innate immunity). 
The tidal volume contains about 0.5 liter of air. During physical activity, the tidal volume and 
the breathing frequency increases in order to increase ventilation. A human at rest breathes 10-
15 m3/day whereas an active worker could easily inhale the same amount of air during an 8-
hour work shift. Lung capacity is also influenced by age, height, length, weight and ethnicity. 
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Figure 1. Anatomy and cell types of the respiratory tract [37] 
Bronchial epithelial cells line the lower airways and play an important role in protecting the 
host against inhaled xenobiotics. Several types of cells comprise the human bronchial 
epithelium: ciliated cells (50-70%), basal cells (30%), mucus producing goblet cells (<25%) 
and Club cells (1-11%) [38, 39]. 
Ciliated cells line the airway epithelium from larynx down to the last generation of 
bronchioles. The coordinated beating of the cilia facilitates transport of the mucus to the 
pharynx. The ciliary axoneme is characterized by the two central singlet and nine outer doublet 
microtubules, about 0.25 µm in diameter and can vary in length from a few micrometers to up 
to 2 mm [40]. Ciliated cells originate from the basal cells which are considered stem cells as 
these could also mature into the other functional epithelial cells [41]. 
Goblet cells are membrane-bound mucus producing cells. The mucus consists of water, ions, 
and mucins with the most prominent being mucin 5AC (MUC5AC). Mucus forms a physical 
barrier in the airways and is important for the mucociliary clearance by trapping inhaled 
particles. Overproduction of mucus is characteristic for acute and chronic respiratory diseases 
like bronchitis, asthma and cystic fibrosis [42]. Meta- and hyperplasia of goblet cells is 
observed in chronic bronchitis and can be induced by IL-4 and IL-13 in vitro [43, 44] 
Club cells formerly known as Clara cells, are recognized in electron microscope by their 
electron-dense lamellar bodies. These cells also have stem cell properties. In the lung, the club 
cells contain the highest concentration of cytochrome P450 oxidase, important for metabolism 
of xenobiotics. Club cells can produce the pro-inflammatory club cell protein: CC16 (also 
known as CC10 or uteroglobin). In COPD patients and smokers, CC16 in serum and BALF are 
significantly lower than in healthy non-smoking individuals [39, 45]. 
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THE IMMUNE SYSTEM 
Innate Immune System 
The second line of defense of the airways is the nonspecific innate immune system. Consisting 
of circulating phagocytic macrophages, dendritic cells and neutrophils, it acts together with the 
structural cells (epithelial cells, Club cells, mast cells and fibroblasts) to provide host defense. 
Macrophages in the airways, called alveolar macrophages (AM), have two origins: resident 
macrophages or monocytes recruited from blood into the lung and differentiated into 
macrophages. The former have good phagocyting capacities while the monocyte-derived AM 
have enhanced abilities to initiate an acquired immune response by secreting and responding 
to a range of effector molecules [5]. Phagocytosis includes several crucial steps required for 
full functionality, which may be impaired by air pollution and cigarette smoke [46]. Like T-
cells, also macrophages can polarize into the pro-inflammatory M1 or anti-inflammatory M2 
subtypes. Stimulation with LPS , IFN-γ and TNF-α will activate the classic M1, which is able 
to resist pathogens and excrete pro-inflammatory cytokines and reactive oxygen and nitrogen 
intermediates [47]. The polarization into M2 is initiated by IL-4, IL-10 and IL-1 [9, 48].  Diesel 
exhaust particles and cigarette smoke also activate M2, whereas air pollution PM rather seems 
to activate M1 [49]. Although AM can produce many cytokines, they likely are not likely the 
main contributor in the airways of cytokines, especially the late-phase ones which lymphocytes 
produce [46]. 
T-cells lymphocytes are part of the adaptive immune system and consist of many subsets of 
cells including CD4+ T-helper cells and CD8+ cytotoxic cells. Originating from bone marrow, 
T-cells mature in the thymus and are finally activated and differentiated to Th or Tc cells in the 
body. Depending on the activation, the T-cells polarize into pro-inflammatory cytokine 
releasing Th1/Tc1 or anti-inflammatory cytokine releasing Th2/Tc2 cells[50]. The “innate” role 
of T-cells cannot be dismissed as some subsets, like memory and regulatory T-cells, express 
TLRs [51-53]. 
Neutrophils are the most abundant leucocyte in the circulating system and important for the 
host defense against pathogens. The cell is short-lived (hours-days) but upon migration 
(infiltration) into inflamed tissue (by chemo-attractants like CXCL8 released by macrophages) 
it’s life-span is extended [54]. After the cells have eliminated the invaders by phagocytosis they 
undergo apoptosis [55]. During the phagocytosis, the neutrophil requires additional oxygen 
which in turn lead to the production of reactive oxygen species (ROS) that in itself could 
increase the inflammation [56]. 
The Pattern Recognition Receptors, PRRs, is a family of preserved proteins crucial for the 
innate immune system, but also important for interacting with the adaptive immune cells. The 
receptors are present in immune cells and both endo- and epithelial cells, located on the cell 
membrane as well as in the cytoplasm and can bind pathogen-associated molecular patterns 
(PAMPs) or danger-associated molecular patterns (DAMPs). Four families have been 
identified: toll-like receptors (TLRs), nucleotide binding and oligomerisation domain-like 
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receptors (or NOD-like receptors (NLRs)), C-type lectin receptors (CLRs) and retinoic acid- 
inducible gene 1-like receptors (RLRs) [57]. 
The fruit fly Drosophilia melanogaster toll gene and toll receptors were discovered 20 years 
ago and soon thereafter, the first mammal homologue was consequently named toll-like 
receptors or TLRs [58]. Currently twelve TLRs – ten in humans – have been identified, which 
each recognize specific PAMPs. Six are expressed on the cell surface: TLR1, TLR2, TLR3, 
TLR4, TLR5 and TLR6 whereas four are located in intracellular vesicles like endosomes: 
TLR3, TLR7, TLR8 and TLR9. Many studies have tried to elucidate the ligands of the different 
TLRs but often the sample preparations were contaminated with LPS or other potent immune-
activators, thus more research is required [59]. 
Important ligand(s) for this thesis is ambient PM and especially organic swine dust which could 
contains both Gram-positive and -negative bacteria and fungi which are recognized in humans 
predominantly by TLR2 and TLR4 [9, 60]. 
TLR2 was discovered 1999 and is an important receptor for peptidoglycans [61], however it 
is also one of the most non-specific TLRs in terms of ligand binding. It binds exogenous 
lipoteichoic acid (LTA), lipoproteins and LPS from non-enterobacteria, but also endogenous 
ligands like heat-shock proteins [59, 62]. The receptor is located on the cell surface and 
recognizes its ligands by forming heterodimers with TLR1 or TLR6 [57]. To induce the release 
of pro-inflammatory cytokines and chemokines, TLR2 activates the MyD88-dependent 
pathway that triggers NF-κB that initiates the inflammatory release of cytokines and 
chemokines [63]. 
The soluble form of TLR2, sTLR2, is present in many compartments including human plasma, 
BALF, sputum, saliva and breast milk [64]. Shedding TLR2 from the plasma membrane of 
sputum neutrophils into sputum of smokers [65] might be a protective mechanism to reduce 
the numbers of receptors and thereby the pro-inflammatory host defense. 
Farmers´ blood monocytes express less TLR2 compared to smokers and healthy controls [24], 
whereas data on COPD-patient are ambiguous [66, 67]. TLR2 expression in AM from COPD 
patients have also been shown to be inconsistent [68, 69]. Smokers have lower TLR2 AM 
expression [66] and smoking COPD patients lower expression of TLR2 on sputum neutrophils 
than non-smoking healthy controls [65]. 
Endotoxins were mentioned in the end of the 19th century, LPS was discovered in the 50’s and 
the Gram-negative bacteria-induced sepsis has been known since the mid 60’s. Yet it was not 
until the end of the last century that the first human TLR was identified: TLR4. Soon it was 
clear that this was the missing link between adverse human effects and the innate immune 
system and the discovery was awarded the Nobel prize in 2011 [58]. The main and thoroughly 
studied TLR4 ligand LPS also called endotoxin is the major component of the outer membrane 
of Gram-negative bacteria. LPS is shed in small amounts during bacterial growth and binds to 
the LPS-binding protein (LBP) in plasma. The complex is delivered to the cell-surface receptor 
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TLR4 that forms a complex with MD2 and CD14. Not only LPS could be part of the 
TLR4/MD2/CD14/LPB-complex but also endogenous ligands like heat-shock proteins are 
possible agonists even though they require very high concentrations to activate TLR4 [59]. 
LPS has high affinity for the receptor and is likely present in swine dust, thus it is unlikely the 
endogenous ligands are responsible for the very high immunomodula-tory properties. Similarly 
to sTLR2, a soluble form of TLR4 has been found in saliva and plasma in humans [64, 70]. 
Although TLRs were discovered at the end of the 90’s, CD14 (a co-receptor of TLR4) had 
already been discovered in 1990 [71]. It is a LPS-binding receptor bound to the cells surface of 
monocytes, macrophages and neutrophils but exists also abundant as soluble form (sCD14) in 
serum, sputum and BALF [65]. After binding of LPS to LPB, either membrane-bound or 
soluble CD14 presents LPS/LBP to the TLR4/MD2 complex. Thereby, the soluble form is also 
able to induce LPS-activation in also low membrane-expressing cells like epithelial and 
endothelial cells [72]. If LPS is present in high concentrations, sCD14 has been shown to 
relocate CD14 membrane-bound LPS to plasma lipoproteins. CD14 binds not only LPS, but 
also peptidoglycans, which cannot activate epithelial and endothelial cells like LPS does [73]. 
Upon CD14-initatied LPS-activation the pro-inflammatory production of cytokines is 
commenced. As sCD14 in liver cells induce expression of IL-6, sCD14 is considered an acute 
phase protein [74]. 
Inflammatory mediators 
Interleukin-8 (IL-8) or CXCL8 is a chemokine produced by many types of cells including 
macrophages, epithelial cells and endothelial cells and is induced by pro-inflammatory 
cytokines, viruses and bacteria including LPS. Major biological activities include promoting 
adhesion of monocytes and fibroblasts as well as functioning as a chemoattractant allowing 
neutrophils to infiltrate into the airways, causing respiratory burst and inducing MMP-9 release 
[75]. 
Interleukin-6 or IL-6 is a pro-inflammatory cytokine produced by immune cells like alveolar 
macrophages, monocytes and neutrophils but also epithelial cells and fibroblasts. The release 
of IL-6 can be induced by cell stress or damage caused by UV, ROS, LPS, viruses etc. Via the 
bloodstream, IL-6 enters the liver where it induces acute phase proteins like C-reactive protein 
(CRP) [76]. The concentration of CRP is often measured in primary care units as a biomarker 
for acute or ongoing inflammation caused by bacteria rather than virus. Although the cytokine 
IL-6 itself likely acts by multiple mechanism and is important for the pathogenesis of 
respiratory diseases such as asthma and COPD [77]. 
Soluble suppression of tumorigenicity 2 or sST2 is one of four isoforms of ST2, which is the 
target receptor of the newly described IL-1-like cytokine IL-33. The binding of IL-33 to sST2 
inhibits the binding to membrane-bound isoform ST2L and thereby acts as a decoy receptor. 
The ST2L is only expressed in Th2-cells, mast cells and cardiomyocytes whereas the soluble 
form is present in almost all living cells. The increased expression levels of sST2 in heart cells 
as a response to myocardial stress including infarction is well studied. Also in respiratory 
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inflammation, the IL-33/ST2 activates Th2 effector cells and influence Th2 related cytokines 
like IL-4, IL-5 and IL-13, all important in e.g. asthma and pulmonary fibrosis. Serum levels of 
sST2 have been shown to be higher in COPD- [78] and asthma patients during exacerbations 
than in controls [79, 80]. Exposure to LPS and swine dust increase serum sST2 in healthy 
controls, but not in swine farmers [81]. 
IL-13 is a regulatory anti-inflammatory cytokine produced primarily by Th2-cells but to some 
extent also mast cells, eosinophils and macrophages. Numerous studies show that IL-13 
induces mucus hypersecretion and data from animal models indicated that IL-13 is crucial for 
asthma and COPD development. The IL-13 concentration in blood is higher during 
exacerbation of asthmatics compared to during non-episodes, which is not found in COPD 
patients in general [82, 83]. Yet comparing smokers with and without chronic bronchitis, the 
number of IL-13 expressing cells in bronchial submucosa is higher in the smoker with chronic 
bronchitis [84]. 
Matrix metalloproteinase-9 or MMP-9 belongs to a family of zinc-dependent proteinase 
secreted constitutively by neutrophils and eosinophils and during inflammation by 
macrophages and mast cells. MMP-9 degrades proteins like collagen and elastin of the 
extracellular matrix but can also cleave non-extracellular matrix proteins like chemokines. This 
degradation is important for tissue remodeling, a distinct feature of inflammation of the airways 
in diseases like asthma. Upon secretion of metalloproteinase-1 (TIMP-1) to the extracellular 
space, TIMP-1 can bind and inhibit MMP-9, important for the tissue homeostasis [85]. Steroid-
treated asthma patients increase submucosal expression of TIMP-1 and decrease MMP-9 [86]. 
In COPD patients, the severity of the disease correlates to the serum MMP-9 concentrations 
[87]. 
Airway immune system in disease 
Chronic bronchitis is defined as daily chronic productive cough for at least three months 
during two consecutive years. The increased production of mucus is caused by excessive 
tracheobronchial goblet cell hyper- and metaplasia and increase of the submucosal glands 
leading to a thickening of the bronchial wall. The pathogenesis is unclear but bacterial 
colonisation and the resulting inflammatory response seem to be important for the progression 
of the disease [88]. Of all diagnosed patients, 90% are smokers or ex-smokers [89]. Chronic 
bronchitis is one of the most common features co-existing with chronic obstructive 
pulmonary disease (COPD). Up to half of smokers develop COPD [90] and non-smoking 
females are more likely to develop COPD than non-smoking men [91]. 
According to the GOLD document, COPD is a defined as a preventable and treatable disease 
characterised by persistent respiratory symptoms and airflow limitation due to airway and 
alveolar abnormalities often caused by exposure to harmful particles and/or gases (GOLD 
2018). The diagnosis is based on medical history together with spirometry where FEV1/FVC 
<0.7 after bronchodilatation. Lung function, assessed as FEV1 in percent of predicted value, 
defines the stage of COPD, from mild to very severe. 
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Inflammatory cells like neutrophils, macrophages and cytotoxic CD8+ T-cells in combination 
with epithelial cells are important for the progression of COPD. They induce a cascade of 
events, including the release of neutrophilic chemoattractant CXCL8, and matrix 
metalloproteinases (MMPs), which leads to a breakdown of connective tissue and development 
of emphysema [92]. Many patients with COPD and emphysema are skinny, may have a barrel 
chest and are often observed leaning forward sitting to facilitate breathing. The most common 
symptoms in COPD are productive cough, wheezing, breathlessness (dyspnea) and fatigue in 
more severe disease. During the progression of COPD, acute exacerbations increase in 
frequency and are often triggered by respiratory infection from viruses, bacteria or 
environmental pollutants. To ease the constriction, short-(and long-)acting bronchodilators are 
frequently used in COPD . 
Currently COPD is the fourth leading cause of death in the world [93]. In 2012, COPD 
accounted for 6% of all deaths in the world and most patients suffer for years before dying at 
premature age. It is estimated to be the third cause of death by 2020 as the population is getting 
older but also continued or increased exposure to COPD risk factors; tobacco smoking, biomass 
fuel exposure and air pollution. Occupational exposures to organic and inorganic dust are 
under-estimated risk factors for developing COPD. In the US, more than 30% of non-smoking 
COPD cases are linked to occupational exposure and is likely much higher in countries with 
no or limited regulations for protecting workers’ health [93]. Age and low education also 
constitute risk factors for developing COPD [91]. An additional risk factor is asthma (12-fold 
increased risk of developing COPD after adjusting for smoking). 
Asthma is a common and heterogeneous airway disorder affecting about 300 million people 
worldwide [94]. The prevalence of asthma differs between countries between 1 and 18%. It is 
characterized by chronic inflammation of the airways including wheezing, shortness of breath, 
and cough together with variable airflow limitation. Unlike COPD, the airway obstruction is 
reversible spontaneously or in response to medication. Allergic asthma is the most recognizable 
phenotype, often starting in childhood and associated with family history of atopic dermatitis 
and/or allergy [94]. This type of asthma involves Th2-cells and eosinophilic recruitment where 
the latter is dramatically reduced upon treatment with glucocorticosteroids [95]. Non-allergic 
asthma can be triggered by exercise, infection, aspirin, or cold air. These patients may have an 
increase in eosinophils, but the increase is less pronounced than in allergic asthma, and they 
are less responsive to inhaled steroids [94]. 
Occupational exposure to swine dust induces impaired immune host response among the 
farmers as they develop immunological tolerance to organic dust. This response is similar to 
LPS or endotoxin tolerance, described first in animal studies and later in patients with e.g. 
sepsis or trauma, upon repeated exposure to endotoxins [96]. 
Previously healthy, and never-exposed subjects, who are exposed to swine farm environment, 
often develop ODTS (organic dust toxic syndrome). It is characterized by flu-like symptoms 
like chills, fever and malaise that appears a few hours to half a day post exposure and disappears 
within one to a few days [97]. Never-exposed healthy subjects exposed to swine barns 
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environment increased both CXCL8 in BALF and nasal lavage fluid, the latter positively 
correlated to nasal lavage neutrophils [98]. 
Naïve, healthy volunteers – divided into low and high responders depending on FEV1 outcome 
after high endotoxin/dust exposure – had a higher increase in blood lymphocytes, serum IL-6, 
total nasal lavage cells and nasal lavage CXCL8 in the high responsive group than the less 
responsive group [99]. When comparing never-exposed healthy volunteers to healthy swine 
farmers after 3 hours of swine farm exposure, the never-exposed volunteers had a much greater 
increase in bronchial responsiveness to methacholine and serum IL-6 levels than the swine 
farmers. Lung function was less affected in swine farmers, as FEV1 dropped significantly more 
for volunteers than for farmers post-exposure. Additionally, the volunteers had an increase in 
the number of nasal lavage cells post-exposure while the farmers had no change. This suggests 
that the farmers had developed tolerance to the swine farm environment [100, 101]. 
The blood and sputum differences in expression of PRRs and adhesion proteins among healthy 
swine farmers and never-exposed, healthy volunteers after swine barn exposure was explored 
by Sahlander et al in 2012 [81]. Farmers showed lower levels of sTLR2 and sCD14 in sputum 
and reduced expression of CD14 on sputum neutrophils than controls. Systemically, blood 
monocytes were higher and expression of CD62L and CD162 on blood neutrophils were lower 
in farmers than in controls. The lack of increase in serum sST2 in farmers compared to swine 
farmers after LPS and swine dust exposure [81] could be linked to the reduced cytokine 
response [100] and suggest the development of tolerance development against the effects of 
organic dust exposure. 
When exposing 16 former swine farmers for 3 hours to a swine farm environment, they reacted 
similarly to active farmers; reduced serum TNF-α, monocyte expression of CD14 and HLA-
DR on alveolar macrophages [102] suggesting that endotoxin tolerance persists over time. 
In farmers, it was reported that high endotoxin concentrations did not render expected effects 
like ODTS. The authors speculated that it could be due to non-specificity of the LAL (Limulus 
amebocyte lysate) assay or that not only endotoxin could cause the effect linked to ODTS [103]. 
At present, the influence on β-1,3-glucan on LAL assay is known (see Methods). Additionally 
several studies suggest that peptidoglycan content of the organic dust could be an important 
contributor to adverse effects in humans [23, 101, 104-106] 
Models to study respiratory innate immunity 
Generally, in toxicology and in immunology, animals are used for in vivo studies to learn more 
about events that may occur in humans. The use of animals in research has a long history in 
medicine and toxicology, which led to the discovery of insulin and vaccine and helped 
screening for carcinogenic drugs and other chemicals. There is increased pressure to replace, 
reduce and refine animal testing (3R) by regulatory authorities, non-governmental 
organizations and the public. However, in some instances research on animals might be 
 18 
required in order to understand systemic effects when animal-free replacements are not 
available. 
Toxicity and effects on innate immunity of airborne substances and mixtures can be 
characterized using different models [107], from simple cell lines in submerged conditions, or 
complex organ-like in vitro models to animal studies using (knock-out) rodents, as well as 
controlled human clinical studies, all aiming to understand the hazard(s) to humans. One of the 
main challenges in respiratory toxicology is mimicking the complex relationship of epithelial 
cells of the airways combined with the difficulties to expose the cells or organ to a physical 
form resembling to what could be found in ambient air. 
In some cases, findings are first observed in human in vivo studies and later “confirmed” by 
animal in vivo studies. For instance, the tolerance to organic dust after repeated exposure was 
first found in humans [100] and later in rats [108] and mice [109]. Identifying animal models 
that reflect the human response are useful since they allow for an in-depth evaluation of the 
disease state, including histopathology, that is not possible with the limited samples available 
in humans. 
Both Paper I and II use human in vivo studies with a crossover design (Figure 2). Typically, a 
crossover study includes a limited number of subjects, as the power is higher than for instance 
a case-control or cohort studies as the subjects acts as their own control which reduces the 
influence of confounders. These advantages should be weighed against the disadvantages 
including the risk of dropout possibly due to long study duration and the difficulties assessing 
possible carryover effect. 
 
 
Figure 2. Generic design of a cross-over study.  
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Different organs and cell types have their own challenges. To study the respiratory tract in vitro 
is challenging due to its complex anatomy including the numerous cell types involved and 
exposure of xenobiotics via air-liquid interphase. In academia the traditional in vitro system for 
assessing respiratory hazard potential of inhaled (ultrafine) substances is using one cell type 
and even possibly a cell line which is exposed via the cell culture media into which the (water 
soluble) substance is diluted. This methodology suffers from many flaws since it is far from 
mimicking real-life exposure and cell morphology and interactions [110].  
Commercial exposure systems are available (CULTEX and Vitrocell®) [111] and several 
research groups have developed in-house methods including ALICE, EAVES, NACIVT [112]. 
The methods are often based on electrostatic precipitation of aerosols over the cells. Important 
disadvantages with these exposure systems are alterations of physical characteristics of the 
particles by particle aggregation and droplet formation [111].   
Recognizing the current limitation, the focus of Paper III was on developing an improved 
model that employed co-culturing human cells forming a three-dimensional airway epithelia 
which could be combined with realistic exposure of aerosols in air. This new in vitro model 
could possibly serve as a replacement for future animal studies focusing on local innate immune 
effects, both acute and long-term. 
GLUCOCORTICOSTEROIDS 
Glucocorticosteroids are endogenous steroid hormones and synthetic anti-inflammatory drugs 
used for treatment of chronic inflammation and immune diseases like asthma, rheumatoid 
arthritis and inflammatory bowel disease. Synthetic steroids therapy was initiated 70 years ago 
and was awarded a Nobel prize in 1950 for the discovery of treating rheumatoid arthritis.  
The drug enters the cell and binds to the glucocorticoid receptor (GR), present in the cytosol of 
almost all organs and tissues, and is translocated to the nucleus, where it upregulates anti-
inflammatory proteins and represses pro-inflammatory proteins in the cytosol [113]. 
Endogenous steroids, like cortisol, also bind to GR but also to the mineralocorticoid receptor 
(MR). To avoid adverse effects of the important endogenous systems, drug development has 
focus on improving the specificity of exogenous steroids to bind to GR. Budesonide and 
fluticasone are examples of commonly prescribed inhaled corticosteroids (ICS) for treating 
chronic inflammation in the respiratory tract, like asthma and COPD. Some COPD patients, 
and asthma patients, respond poorly to ICS. Several mechanisms could be the reason behind 
ICS resistance. In an attempt to address the issue of resistance researchers and clinicians have 
tried to identify alternatives but have been hampered by toxicity and unwanted side effects and 
therefore have identified only a few alternative drugs [113, 114]. In addition, those alternatives 
they have identified also have limited effectiveness in some patient groups [115]. 
Phosphorylation of GR via IL-2, IL-4, IL-13, cytokines that are over-expressed in 
corticosteroid resistant asthmatics, can decrease its activity [116]. Yet the mechanisms of 
glucocorticosteroids are complex and even possible pro-inflammatory effects have been 
suggested [117-119].  
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AIMS OF THE STUDIES 
Overall, the aims of the studies were to investigate the host innate immune responses in humans 
– in vitro, in vivo and ex vivo – after exposure to nano-sized palladium and particulate matter 
of organic dust present in swine farms. 
Paper I 
The aim was to compare respiratory effects in healthy subjects after acute exposure to organic 
dust in swine buildings before and after installing particle separators, which aimed to reduce 
particulate matter exposure. 
Paper II 
The aim was to investigate the host innate immune response in vivo in chronically organic dust 
exposed swine farmers after short-term glucocorticosteriods therapy. 
The aim was to elucidate the cellular immune response of AM from chronically organic dust 
exposed swine farmers to ex vivo co-stimulation of glucortocosteroids and/or TLR ligands. 
Paper III 
To develop an organotypic in vitro exposure system; combining human bronchial mucosa 
models with XposeALI® for exposure of nano-sized palladium.
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MATERIALS AND METHODS 
MATERIALS 
Study designs 
In this thesis, both human in vivo and in vitro models have been used. 
Human in vivo crossover studies (described above in Figure 2): 
 Paper I analyse the biological effects of dust reduction intervention in swine stables 
among healthy volunteers (Figure 3). 
 Paper II focus on health effects in swine farmers after budesonide therapy and ex vivo 
stimulations of TLR ligands LPS, petidoglycan or TNF-α with or without budesoinde 
of swine farmers’ alveolar macrophages. 
 
 
 
 
Figure 3. Study design of paper I including perfomred biological and exposure measurements.  
CE: conventional swine building environment, PSE: particle separated swine building environment 
 
In vitro 3-dimensional bronchial mucosa model: 
 Paper III explains the development of a new in vitro model that could possibly serve as 
a replacement for future animal studies focusing on local innate immunity. It focus on 
co-culturing human primary cells and cell lines forming a three dimensional airway 
mucosa combined with a realistic exposure of aerosols present in air. 
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Human study populations 
All subjects gave their informed consent and the studies were approved by the Ethics 
Committee of Karolinska Institutet. 
 Eleven healthy, non-smoking, non-allergic subjects who never had been exposed in 
swine farms were included in Paper I. 
 Fifteeen, healthy, non-smoking, non-allergic swine farmers (>6 months recent 
occupational exposure) were included in Paper II. 
 Alveolar macrophages of a subset of seven swine farmers were used for the ex vivo part 
of Paper II. 
 Primary bronchial epithelial cells (passage 3) from healthy tissue taken during lung 
lobectomy of 3 donors together with a fibroblast cell line (passage 26) were used for 
study III. 
Exposure 
Paper I 
The healthy subjects were exposed twice to organic dust for 3 hours, by being present during 
the weighing of swine in two swine barns. These barns were identical except for one difference, 
the presence of installed cyclones with the aim to reduce the ambient dust concentrations in the 
swine barns air.  
The two barns were identical; area of 550 m2, ventilation air exchange rate of maximum 30 
total air volumes/hour, temperature of 20-22 °C, except on hot summer days when stable 
temperature was about 1-2 degrees warmer than outside temperature, housed 350 swine 
(weighing 90 kg) held on concreate floor with wood shavings given wet feed.  
Pre-installation of the cyclones, both stables were washed clean. Swine were housed 10 weeks 
before first exposure of the the study subjects who were randomised into two groups and 
exposed to the two stables for 3 hours between 8 and 11 in the morning, in a cross-over design 
with 2-3 weeks of washout in between. The stables were called conventional environment (CE) 
and particle-separated environment (PSE). The subjects were exposed during weighing of the 
swine, which generally render high dust exposure due to the intense activity of the swine and 
the farmer. 
Four particle separators/cyclones were installed, one in each corner of the the stable (Figure 4), 
aiming to reduce organic swine dust concentrations of the indoor air. The total air exchanges 
of the cyclones were 3 times per hour. 
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Figure 4. Cyclone design. Generic sketch (above) and the installed Centriclean cyclone and fan below. 
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Paper II 
The swine farmers, chronically occupationally exposed to organic dust in swine barns, inhaled 
budesonide 400 g or placebo twice daily for two weeks the with a 4 week washout period in 
between the two treatments. Throughout the budesonide and placebo treatment periods the 
farmers continued working as usual in the swine stables. To assure chronic swine dust exposure 
the farmers had worked at least 6 months in swine environments prior to entering the study.  
Alveolar macrophages collected from a subset of 7 farmers were grown in 12-well plates and 
stimulated for 6 hours ex vivo with budesonide (10-8 M)  and/or co-stimulated with TLR ligands 
LPS (1 µg/ml), peptidoglycan (1 µg/ml) or TNF-α (10 ng/ml). 
Paper III  
Two types of co-cultured 3D- cell models were used for the experiments; models from 3 
different donors both normal and chronic bronchitis-like models (treated with IL-13 to induce 
increased number of mucin-producing cells). These models were exposed to palladium 
nanoparticles sized 6-10 nm using the XposeALI® module of the PreciseInhaleTM exposure 
system for assuring an even and precise dosing during 3 minutes. The models were assessed 2, 
4, 8 or 24h post-exposure. 
The PreciseInhaleTM exposure platform combined with the XposeALI® module allows for 
exposure of cells to respirable sized aerosols (Figure 5). The small sample of palladium was 
put onto the loading chamber and assembled with the nozzle and the aerosol chamber. A high-
pressure air jet of 100-140 bars was shot through the nozzle, which aerosolize the palladium 
powder into the 300 ml aerosol/holding chamber. The aerosol is further drawn at a speed of 90 
ml/min, to pass by the Casella light dispersion instrument before reaching the XposeALI® 
module. Here the tube diverts into three consecutive branch flows of 10 ml/min that are 
connected with the three inserts of co-culture cell models. To calculate the dose of each insert, 
the signal of the Casella instrument was correlated to the weight of palladium on the end filter. 
In this paper, the substance correlation factor was 0.8648. To achieve target dose, the duration 
of the exposure was altered. The exposure times for the different concentrations were; low dose 
was exposed for 20 seconds, medium dose for 45 seconds and high dose for 3 minutes. This 
corresponds to 250, 400 and 650 ng palladium/cm2  insert/cell surface. To investigate the dose, 
exposed models were dissolved in aqua regia, neutralized to pH 3 and analysed by IPC-MS 
(inductively coupled plasma-mass spectrophotometer). To control for the manual handling of 
the inserts outside incubator environment and for the exposure itself, sham cultures were 
exposed to clean exposure system and only pressurised air. After the exposure, the models were 
incubated for 8 and 24 hours in 5% CO2 at 37 °C before apical medium was collected by lavage 
for 15 minutes and the basal medium from the basal chamber was collected and stored at -80° 
C until further analysis. 
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Figure 5. Exposure system: PreciseInhaleTM platform including aerosol generator, holding chamber and Casella 
combined with XposeALI ® module with exposure hoods and cell inserts. 
Sample collection  
Overall, samples were collected from included study subjects approximately at the same time 
of the day, often early in the morning. Not only for practical reasons but also to avoid the 
influence of circadian rhythm to effect the results. Especially for asthma patients with 
worsening symptoms during the night often around 4 a.m., many parameters like lung function 
and exhaled nitric oxide are effected by circadian rhythm [120-122]. Also the innate responses 
including the cytokine secretion naturally fluctuates during the 24 hours [123]. 
Spirometry is an important measurement for measurement of ventilation. Trained nurses and 
general practitioners can perform the analysis, which helps diagnosing asthma, COPD and 
other lung disorders. The method is simple and quick as well as non-invasive. Yet the analysis 
require the patient to cooperate and to be able to take instructions from the well  trained medical 
staff. Good reproducibility between measurements is a quality requirement. As lung function 
is dependent on age, length and weight, the results are also compared to the general population 
and a percentage of predicted value is calculated. 
Spirometry was performed in Paper I and II. In Paper I, we investigated the lung function on 
three occasions; before and 7 hours after the exposures to swine barn environment with and 
without particle separators in the stable. In Paper II, we investigated lung function before and 
after the two two-week treatments with budesonide and placebo. A wedge spirometer was used 
to measure VC and FEV1. The same trained nurse was assisting the subjects on all occasions. 
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Bronchial responsiveness is a term describing the tendency of airways to constrict to direct 
stimuli such as allergens and non-specific stimuli like cold air, exercise or methacholine. 
Methacholine binds to the muscarinic M3-receptor in the airway smooth muscle cells, which 
causes the airways to constrict. The methacholine challenge test is often used to diagnose 
asthma.  
Exhaled nitric oxide (FENO) was measured using a non-invasive method that has been used 
for assessing airway inflammation for almost 30 years [124]. Nitric oxide is produced by most 
cells both epithelial and endothelial and inflammatory cells in the bronchi and alveoli of the 
respiratory system. During inflammation nitric oxide synthase is induced and these enzymes 
can generate nitric oxide while converting L-arginine. Especially increased levels of nitric 
oxide synthase 2 is found in the airways in asthma and is reduced by steroid treatment. In 
COPD patients the formation of nitric oxide seems to be linked to a different synthase. 
Nevertheless, exhaled nitric oxide is a useful tool in understanding eosinophilic inflammation 
of the airways in e.g. asthma [125]. Important confounders when measuring FENO are ingesting 
nitrate-rich vegetables like spinach [126] and smoking [124]. In Paper I, exhaled nitric oxide 
was assessed according to the ATS recommendations [121] using a single-breath exhalation 
with a flow rate of 50 mL/s.  
Symptoms questionnaire are an easy, non-invasive measurement, but yet efficient, especially 
in understanding intra-subject changes over time or treatments. In Paper I and II, the 
participants were asked to estimate and document body symptoms by marking on a 100 mm 
line (scale) where 0 was no symptoms and 100 unbearable symptoms. Five general symptoms 
(chills, headache, fatigue, muscle pain and nausea) and seven airway-specific symptoms 
(sneezing, stuffy nose, runny nose, coughs, tight chest, shortness of breath and wheezing) were 
recorded by the participants before and after the exposures. Additionally, for Paper I, the 
participants were asked to estimate when, over the course of the day, the symptoms were most 
pronounced. 
Blood sampling was performed on the day of medical examination and 6 hours after beginning 
of each exposure (Paper I) or after 2 weeks of each treatment (Paper II). 
Venous blood was collected in different tubes depending on analysis of interest: serum (protein 
release using ELISA, Paper I and II), heparin (intracellular staining using flow cytometry, 
Paper II) and EDTA (cell surface markers using flow cytometry, Paper I and II) tubes.  
Nasal lavage is simple and rapid to perform and often used for research of the upper respiratory 
tract. In Paper I, it was performed on the day of medical examination and 6 hours post 
beginning of each exposure. Sterile 0.9% sodium chloride (5 ml) was instilled into one nostril 
and 10 s later expelled and collected. The procedure was repeated in the other nostril and the 
samples were pooled. After centrifugation of the lavaged cells, they were counted and the 
supernatant was frozen for future analysis of soluble proteins. 
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Induced sputum is a semi-invasive method to diagnose lower respiratory diseases. It requires 
the patient and the well-trained nurse or technician to cooperate well. Avoidance of excessive 
bronchoconstriction is required but emergency bronchodilators and other drugs should always 
be close [127].   
In Paper II, an experienced research nurse executed induced sputum. After salbutamol 
inhalation, sputum was induced by inhaling increased concentrations of saline whereupon 
subject was asked to cough deeply and finally make an attempt to expectorate sputum. A 
sample larger than 1 gram and macroscopically free from saliva was considered sufficient. 
After filtering and centrifugation, the total cell number and cell viability was determined by 
Trypan blue and the supernatant was stored at -70°C until further ELISA analysis.  
Bronchoalveolar lavage (BAL) is an invasive method that requires sedation and due to this, 
the method is often not the first measure employed to diagnose a patient [128]. Although not 
commonly performed, the collection of bronchoalveolar lavage fluid (BALF) is very valuable 
for research of the mechanisms of respiratory diseases [129]. Additionally, other tissues than 
BALF could be collected during the bronchoscopy, for instance bronchial brushing of the 
epithelial wall. In our study II, bronchoscopy and BAL were performed according to 
established procedures at Karolinska University Hospital [129]. After morphine sedation, a 
flexible fiber optic bronchoscope was inserted via nose or mouth into the lower airways under 
local anaesthesia (Xylocain®). Five aliquots of 50 ml of sterile saline solution were instilled 
into the middle lobe of the right lung, recollected by aspiration and put on ice until further 
analysis. 
Inflammatory mediators from 3D models 
Apical medium was collected by lavaging the epithelial layer with 180 µl of medium for 15 
minutes. The basal medium was collected from the bottom of the well including the cumulative 
secretion. Both apical and basal medium were collected after 8 and 24 hours post-exposure for 
later CXCL8, MMP9 and CC16 analysis. 
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METHODS 
Exposure measurement 
Particle characterization, exposure and uptake 
In Paper I, scanning electron microscopy/energy dispersive spectroscopy SEM/EDS was used 
for analysing dust, collected on stubs during the first 20 minutes in the swine farms on the days 
of exposure. The stubs got saturated despite the short collection time so the analysis was semi-
quantitative. Elemental analysis of 150 particles on each stub was performed  
In Paper II, palladium nanoparticles were synthesized by Bradley’s reaction of solvothermal 
decomposition of Pd(II)-acetylacetonate [130]. For assessing purity of the palladium 
nanoparticles SEM/EDS was used.  
For the crystallinity assessment of the palladium particles X-ray powder diffraction was used. 
Palladium size was determined by image analysis using transmission electron microscopy 
(TEM). The palladium dose was determined by ICP-MS and the palladium post-exposure 
uptake of the models was detected using TEM after 2, 4, 8 and 24 hours incubation. 
Bronchial mucosa model establishment 
In Paper III, we develop in vitro mucosa-like models; one normal “healthy-like” and one IL-
13 stimulated “chronic bronchitis-like” model [45]. This procedure requires approximately 30 
days as shown in Figure 6.  
To create the models, PBEC were seeded (1×105 cells/cm2) on pre-coated 0.4 µm transwell 
inserts in a 12-well plate. Complete keratinocyte serum-free medium (KSFM) medium (with 
all supplements) were added (1 ml) to basal and apical side of the insert and culture medium 
was changed every other day. After one week, the number of cells reached around 3×105 
cells/cm2 and the cells were confluent on the insert. The insert was turned upside down, placed 
in a sterile petri dish and 100 µl of complete Dulbecco's modified eagle medium (DMEM) 
medium (with all supplements) containing 1×104 cells/ml of fibroblasts was added to the 
downside of the insert membrane. The fibroblast-containing insert was covered and incubated 
for 30 min at 37 °C while 50 µl complete DMEM was added every 10 minutes to prevent 
desiccation. Once fibroblast attached to the membrane, the insert was put back into the twelve-
well plates in its normal position with 1 ml complete KSFM medium on both sides of the insert. 
The model was cultured submerged overnight in incubator to allow the two cell types adapt to 
each other. To initiate the air-liquid-interface (ALI) culturing of the models, all medium was 
removed and 800 µl ALI medium (complete KSFM medium supplied with calcium chloride, 
ethanolamine and retinoic acid) was added to the basolateral chamber. The model is viable in 
5 % CO2 at 37 ºC up to 4 weeks by changing the ALI medium in the basolateral chamber every 
other day. After 3 weeks of ALI culturing, the cell number of our models reached about 1.4-
1.8×106 cells/cm2.  
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To initiate chronic bronchitis-like models, the models were stimulated by addition of 1 ng/ml 
and 10 ng/ml recombinant human IL-13 to the ALI medium. All the other procedures were 
identical to as above.  
 
 
 
 
 
 
 
Figure 6. Timeline and main steps in bronchial mucosa model establishment (performed under sterile condition 
and cultured in 5% CO2 at 37°C)  
1) Apical PBEC seeding in semi-porous 0.4 µm transwell membrane 2) Basolateral seeding of fibroblast MRC-5 
3) Removal of medium and medium addition only to basal chamber 4) Cell differentiation during culturing under 
air-liquid interphase. (Adaptation from [45]).  
 
3D cell model characterization and viability 
To assess the morphology of the differentiated co-cultured bronchial mucosa models light-, 
confocal microscopy, scanning- and transmission electron microscopy and transepithelial 
electrical resistance (TEER) were used.  
For histological analysis, the membranes containing the models were cut out of the inserts, 
fixed, dehydrated, paraffin embedded and sectioned before being stained with hematoxylin and 
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eosin (H&E) or periodic acid-Schiff (PAS). H&E staining is one of the most commonly used 
stains used in histopathology for staining nuclei and cytoplasm/extracellular matrix 
respectively [131]. PAS staining is useful for identifying molecules found in connective tissue 
and mucus [132]. 
To assess ciliated cells and mucin producing cells of the models using confocal microscopy, 
the fixed models were stained with mouse anti-acetylated alpha tubulin antibody and rabbit 
anti-mucin 5AC antibody, respectively followed by secondary antibodies (Alexa Fluor® 488-
conjugated goat anti-mouse IgG and Alexa Fluor® 555-conjugated goat anti-rabbit IgG), 
respectively. The models were mounted on microscope slides with DAPI (4′,6-diamidino-2-
phenylindole). Negative control slide was prepared by excluding the primary antibodies. 
Images were captured and visualized using a LSM700 confocal microscope. 
For scanning electron microscopy, the model membranes were cut out from the insert and 
fixed in glutaraldehyde in sodium cacodylate buffer containing sucrose and calcium chloride. 
The fixed membranes were dehydrated in ethanol and dehydration were completed by critical 
point drying under CO2 for best sample morphology preservation. The membranes were 
mounted and sputter-coated for examination in scanning electron microscope.   
For transmission electron microscopy, the model membranes were cut from the insert and 
fixed in glutaraldehyde in sodium cacodylate buffer containing sucrose and calcium chloride. 
The membranes were post-fixated in osmium tetroxide in sodium cacodylate buffer for 2 hours. 
After dehydration, the membranes were embedded in LX-112 solution and sectioned using an 
ultra-microtome.  After contrasting the sections with uranyl acetate and lead citrate, they were 
examined in a Tecnai 12 transmission electron microscope. 
To measure the integrity of tight junctions in an in vitro system, the non-invasive 
transepithelial electrical resistance (TEER) is a reliable and sensitive method [133]. In study 
III, EVOM voltage-ohm meter and chopstick electrodes were used. The TEER values were 
calculated from the mean of 8 inserts per condition, subtracting the TEER value from an insert 
without cells and multiplied by membrane growth of 0.9 cm2. 
The PBEC viability was assessed by trypan blue staining. Trypsinised cells in suspension (10 
µl) was mixed with 10 µl 0.4% trypan blue and 200 cells were counted to determine viability. 
To assess the models, 200 µl 0.2% trypan blue was added on top of the models. 200 cells in 
four sections of the model was counted to determine the viability. PE-annexinV/7-AAD-
staining kit stained 2,000 cells from the trypsinised models and the apoptotic rate was detected 
using flow cytometry. 
Analysis of proteins 
In all the papers of this thesis sandwich enzyme-linked immunosorbent assay (ELISA) was 
used to detect the soluble proteins of the samples. The method requires two antibodies, first the 
microplate was coated with capture antibody, second the standard and samples were added, 
and finally the enzyme-linked detection antibody. Once the stopping substrate was added, the 
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colour in the microplate well is proportionate with the antigen concentration of the sample. The 
methodology have a high specificity and is sensitive (low detection limits) and is suitable for 
complex matrices like serum, sputum, BALF and cell culture supernatant. Duo-set ELISA kits 
from R&D Systems and in-house methods (IL-6 and CXCL8) were used to detect the following 
proteins concentrations: CXCL8 (Paper I, II & III), sST2 (Paper I, II), IL-6 (Paper I), sTLR2, 
sCD14, IL-13 (Paper II) and MMP9 and CC16 (Paper III). 
Flow cytometry uses multiple laser beams of different wavelength to measure physical and 
chemical properties of individual cells from blood, sputum, BALF etc. The cells of interest are 
stained with fluorescent labels and diluted in sheath fluid before injection into the flow cell and 
pass the lasers in a narrow cell-wide channel. The laser excites the labels of the cells causing 
them to emit light of a certain wavelength. Multiple filters detect cell size (forward scatter, 
FSC), granularity (side scatter, SSC) and intensity of the fluorochrome-conjugated antibodies. 
Both the number of the positively labelled cells and the mean (or median) fluorescence intensity 
can be detected. Throughout the studies the group changed from using an old, robust and 
“simple” BD FACSCaliburTM (Paper I) to a high-tech multi-colour LSRFortessaTM (Paper II 
and III), now allowing usage of complex panels and advanced fluorochromes. 
Intracellular expression of cytokines and chemokines in the cell cytoplasm or nucleus can also 
be detected using flow cytometry as performed in Paper II. Here, the T-cell polarization was of 
interest hence expression of anti-inflammatory IL-13 and IL-4 and pro-inflammatory IL-2 and 
IFN-γ were analysed. To increase the intracellular expression of cytokines the blood was first 
stimulated by PMA and ionomycin. To hinder the cytokines to be secreted from the blood cells 
they were treated with brefeldin A that inhibited the protein transport by redistributing proteins 
from the Golgi complex to the endoplasmic reticulum [134]. After fixation and 
permeabilisation of the plasma membrane the cells are stained with cytokine antibodies and 
then analysed by flow cytometry using BD LSRFortessaTM.  
Exposure measurements of endotoxin and dust were performed (Paper I) using portable 
pumps with IOM filter cassettes equipped with Teflon filters. The samplers were placed in the 
breathing zones on three participants at an airflow rate of 1.9–2.0 L/min. The filters were 
extracted in sterile water and the endotoxin concentration was analysed. 
Analysis of endotoxins is based on kinetic-chromogenic technique and performed using the 
Limulus Amebocyte Lysate (LAL) assay from Charles River Laboratories, USA. It uses 
enzyme in isolated amebocyte cells from Atlantic horseshoe crabs that upon endotoxin 
induction can cleave the colorimetric substrate [135]. The methodology is analytically 
straightforward but very sensitive. The methodology is developed for assuring safe pharma so 
the detection limit is extremely low (0.1 EU/ml). Achieving trust-worthy, repeatable results is 
challenging especially in high-containing samples like swine dust where endotoxin is likely 
bound to the complex dust particles and requires extensive dilution for measurable results [21, 
136, 137]. Interference of fungal β-1,3-glucan, present in swine dust, is another challenge [135] 
that was overcome in paper I by using endotoxin specific buffer containing carboxymethylated 
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curdlan that block the reaction of β-1,3-glucan with LAL (BG120, Charles River Laboratories, 
USA).  
For valid results in Paper I, beyond using non-contaminated lab ware including depyrogenated 
borosilicate test tubes, special 96-well polystyrene plates and endotoxin-free water samples, 
the samples required vigorous vortexing and stable hot plate to assure sample temperatures of 
37 °C.  
Analysis of mRNA 
Polymeras chain reaction (PCR) amplifies DNA or RNA into measurable amounts.  
In our studies we extracted total RNA from the samples (alveolar macrophages stimulated ex 
vivo in Paper II and 3D model PBEC stimulated in vitro in Paper III) and assessed its quality 
by measuring spectrophotometric absorbance ratio at 260/280 nm. First-stranded cDNA was 
synthesized by revere transcription of total RNA, from which reverse transcription PCR was 
performed including the primers of interest. Results were adjusted for an internal control gene 
and expressed as ΔΔCt (relative values) and presented as fold differences compared to the 
experimental control where ΔCt=Ct (gene of interest) – Ct (internal control gene). 
Paper II used RT-PCR to understand the impact of in vivo budesonide treatment and ex vivo 
stimulation of TLR ligands and/or budesonide in swine farmers’ alveolar macrophages mRNA 
expression on common pattern recognition receptors and inflammatory mediators. Here we 
analysed the transcript of genes involved in pro-inflammation (CXCL8), innate immunity 
(TLR2, TLR4, CD14, LL37), mucus (hyper)secretion (IL13, SLPI), oxidative stress (glutathione 
peroxidase (GPx), SOD3) and tissue repair (TIMP). Ribosomal protein L32 (RPL32) was used 
as internal control gene.  
Paper III used RT-PCR to validate the differentiation of cells into a mucosa-like model. Here 
we analysed forkhead box protein J1 (FOXJ1) a transcription factor involved in ciliogenesis, 
MUC5AC expressed by mucus producing cells, club cell protein (CC10/CC16) produced by 
non-ciliated club cells and keratin-5 (KRT5) that is expressed primarily in basal cells. Beta-
actin was used as internal control gene. 
Statistics 
Non-normal (or unknown distribution) distributed data was presented as median with 25-75th 
percentiles. Lung function parameters, symptoms and body temperature were considered 
normally distributed and presented as mean values and 95% CI.  
Statistical within group comparisons were assessed by the Friedman test followed by the 
Wilcoxon signed rank test when appropriate. 
Statistical analyses for all papers were performed using STATISTICA (StatSoft). 
In Paper I, to analyse symptoms, pre-exposure data from the same morning were deducted from 
post-exposure data for the two exposure occasions and the differences compared.  
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In Paper II, correlations between biomarkers and lung function were assessed using Spearman 
rank correlation test. Student t-test was used for determining the influence of carryover between 
the treatments. In this paper also the statistical analysis software STATA® was also used. 
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RESULTS AND DISCUSSIONS 
PAPER I 
The aim of this study was to compare respiratory effects in healthy volunteers after acute 
exposure to organic dust in swine buildings before and after installing particle separators, also 
called cyclones, aimed to reduce dust exposure (PSE: particle separated swine building 
environment and CE: conventional swine building environment). 
The exposure of the subjects were performed at four different days during June and July. 
Climate data collected by Swedish Meteorological and Hydrological Institute revealed 
temperature differences, from 14 to 30 °C during the study period (Table 1). The relative 
humidity was approximately 45 % except for the coldest day when it was 65 %. These 
meteorological parameters could influence both the outdoor and indoor air conditions and the 
ability to form and hold particles in the air [138, 139].  
Table 1. Outdoor conditions and number of particles per size fraction on days of exposure [105]. 
 
Endotoxin was measured by three portable devices at the four days of exposure. The inter-filter 
variability, as well as the intra-filter variability as measured in the aliquots, was large and 
ranged from below detection limit to 144 EU/ml. It is clear from the literature and from 
performing these LAL analysis that it is optimized for very low endotoxin concentrations 
typically found when assuring endotoxin free pharmaceuticals and not for high concentrations 
found in agricultural environments [137]. Round-robin analysis have, despite using the same 
or different protocols, shown difficulties in achieving similar results [136]. Yet the results give 
an indication of the presence of endotoxins in swine building environment. Whether particle 
separators were used or not, seemed not to be important for the endotoxin concentrations in air. 
Temperature appeared to influence the endotoxin concentration; the higher the temperature the 
lower the endotoxin concentration (Figure 7A). Even if the stables are ventilated, there is no 
air-conditioning why hot outdoor temperatures around 30°C are also reflected in hot indoor 
temperatures. Temperature also influences the physical activity of the swine and on hot days, 
the swine tend to lay still on the cold concrete floor which could likely reduce the endotoxin 
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levels. Low endotoxin levels during warm days have been reported in Danish dairy farms [20] 
and during summer vs winter in Dutch [140] and Canadian [141] swine farms. 
When comparing the two stables (PSE and CE) in terms of particle number differences, the 
installation of the cyclones reduced the particle fraction sized 0.3-0.5 µm the most without 
being impacted by the 15 °C difference in outdoor temperature (Figure 7B). Also the slightly 
larger fractions 0.5-1 µm and 1-5 µm reduced in numbers in the PSE compared to CE. For 
these fractions in CE, the temperature seemed to influence the numbers as the cold day had 
much higher particle numbers than the warm day (Table 1). This could again be influenced by 
the ventilation of the stables as the warmer the stable the higher the ventilation rate. Increasing 
the ventilation possibly reduce the smaller airborne particles better than the larger (that tend to 
settle faster to the ground). Yet the smallest particles (0.3-05 µm) could be too small to be 
affected by the ventilation and being airborne for the longest time they could reach the particle 
separators. 
 
Figure 7. A: Endotoxin concentrations and outdoor temperature on the days of exposure. Three IOM samplers 
were used on each of the 4 days of exposure, to collect endotoxin samples. B: Particle numbers, sized 0.3–0.5 mm, 
measured over time in the swine buildings during exposure (dates included). CE: conventional swine building 
environment, PSE: particle separated swine building environment. [105] 
Lung function (FEV1, VC) and bronchial responsiveness (PD20FEV1, PC20FEV1) were clearly 
reduced by the acute exposure to the two swine buildings (Table 2), yet with no difference 
between CE and PSE. 
Exhaled nitric oxide increased after both exposures in PSE and CE with no difference between 
the groups (Table 2). Previously, in similarly exposed healthy subjects nitric oxide levels in 
exhaled air was doubled, which could be prevented by wearing a half-mask with particle filter. 
The personal protective equipment did not protect from the increase in bronchial 
responsiveness [142]. In a more recent study [34], wearing different types of face-masks did 
not protect from the increase in NO caused by 3 hours exposure in swine barns. This conflicting 
finding could be explained by the late follow-up (7 hours after initiating exposure) or by lower 
airborne inhalable dust concentrations. In all, this suggests that different particles are 
responsible for different mechanisms of action during respiratory inflammation. 
  37 
Table 2. Lung function data and exhaled nitric oxide before and after the two exposures (CE: Conventional 
swine house environment, PSE: Particle separated swine house environment). Data are presented as mean and 
95% confidence interval. Statistical significance is considered p<0.05, n=11. 
.Lung function parameters Pre exposure Post CE Post PSE 
P-values 
(pre exposure  - CE 
pre exposure – PSE 
CE - PSE) 
FEV1 (liter) 
4.17 
(3.73-4.60) 
4.05 
(3.58-4.51) 
4.03 
(3.59-4.47) 
0.02 
0.009 
0.79 
FEV1 (% predicted value) 
99 
(94-104) 
96 
(91-101) 
96 
(90-101) 
0.02 
0.01 
0.86 
VC (liter) 
4.68 
(4.15-5.22) 
4.60 
(4.04-5.16) 
4.53 
(3.99-5.06) 
0.01 
0.01 
0.26 
VC (% predicted value) 
91 
(85-97) 
90 
(83-96) 
88 
(83-93) 
0.01 
0.01 
0.20 
PD20 (mg) 
3.81 
(0.47-7.15) 
1.95 
(-1.84-5.73) 
1.85 
(-1.53-5.23) 
0.008 
0.005 
0.86 
PC20 (mg/ml) 
8.16 
(1.65-14.7) 
4.00 
(-3.29-11.30) 
3.84 
(-2.68-10.35) 
0.008 
0.005 
0.95 
NO (ppb) 
14.05 
(11.53-16.56) 
19.68 
(16.67-22.70) 
19.55 
(17.13-21.96) 
0.01 
0.005 
0.86 
 
Analysing blood leucocytes and nasal lavage fluid cells, all but blood eosinophils increased in 
number after the two exposures (p≤0.013) but with no difference between CE and PSE (NAL 
cells; Figure 8). Also the ratio of CD4/CD8+ blood lymphocytes increased after CE exposure 
(p=0.05) but without any difference between the two exposures. 
After the CE exposure, TLR2 and TLR4 expression on blood monocytes increased (p=0.016 
and p=0.017 respectively) whereas CD14 was not altered. On blood neutrophils the surface 
expression of CD14 was significantly reduced after CE (p=0.008) and PSE (p=0.003) 
exposures. No differences between CE and PSE were observed for the surface expression of 
TLR2, TLR4 or CD14 on blood monocytes or neutrophils. 
Similarly sCD14 in serum was reduced after CE exposure compared to pre-exposure (p=0.05) 
without any difference between the CE and PSE. Soluble ST2 in serum was not affected by the 
exposures and below detection limit in nasal lavage fluid.  
The cyclones clearly reduced the smallest of the ambient swine dust particles. This reduction 
could possibly be linked to the altered host innate response of the nose where both pro-
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inflammatory mediators IL-6 and CXCL8 increased after the two exposures (p≤0.03) but 
significantly more after CE exposure than PSE exposure (p=0.02 and p=0.04 respectively) 
(Figure 8). In serum, IL-6 and CXCL8 were below detection limit. 
 
 
 
Figure 8. Individual data of IL-6 (open circles) and IL-8 (open squares) in NAL and number of NAL cells 
(closed triangles). Medians are connected before and after exposure in CE and PSE. *p<0.05, **p<0.01, n=11. IL: 
interleukin, NAL: nasal lavage, CE: conventional swine building environment, PSE: particle separated swine 
building environment. [105] 
The symptoms questionnaire showed that almost all symptoms increased after exposure to the 
swine building environments. After CE, the subjects reported more pronounced symptoms 
directly after three hours exposure and still after another three hours. After PSE, the subjects 
also reported increased symptoms but the duration of the symptoms were shorter and often 
back to baseline after six hour from the start of the exposure. Headache was the only symptoms 
where CE gave significantly higher VAS score than PSE (p=0.03). Body temperature measured 
orally was significantly higher after CE exposure than PSE exposure (p=0.016). Compared to 
the local effects of IL-6 and CXCL8 in the nose described above, headache and body 
temperature are systemic effects that apparently also were affected by the lower concentration 
of fine particles (0.3-0.5 µm). Increased body temperature and induced innate immune system 
is closely linked [143]. Rodents injected with LPS induced TLR4 and release prostaglandin E2 
and IL-6 which travels through the blood-brain barrier to initiate fever. Systemic IL-6 was not 
detectable in serum in this study. In non-naïve but currently non-farmers IL-6 was detected at 
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its peak in blood one hour after 3 hours of exposure to swine dust in a swine farm occupational 
setting [102]. The analysis used by Hoffmann et al was slightly more sensitive than the method 
that we used (detection limit of 0.7 pg/ml compared to 3 pg/ml). In our study the blood samples 
were taken 6 hours after the start of the exposure which could have been too late to find the 
peak levels combined with natural low levels of plasma IL-6 concentrations around noon 
because of the circadian variation [144]. Similarly, the IL-6 peak appeared 1-2 hour after the 3 
hour exposure when detecting IL-6 in volunteers exposed to organic dust in swine buildings 
[100, 145]. In our study, the surface expression of TLR4 and TLR2 on monocytes were 
increased after CE and not PSE, which could be linked to the higher body temperature even if 
IL-6 could not be detected systemically.  
The biological host response was reduced among the volunteers in the particles separated swine 
farm. One of the variables that we considered was whether the size of the particles had an 
impact on the response, as it was observed that there was fewer particles in the fine fraction 
when the cyclones were used. Thus, the number of available particles able to interact with the 
respiratory system and each cell and PRRs was reduced. Upon particle exposure, the cells in 
the respiratory tract are stimulated to produce reactive oxidative or nitrogen species which 
could trigger the release of pro-inflammatory IL-6, CXCL8 and TNF-α. Alternatively, 
indirectly the particles can induce apoptosis. DAMPs will be released by the dying cells which 
would bind to TLRs and consequently initiate the release of cytokines and chemokines. IL-6 
induces acute phase proteins production including C reactive protein that also could trigger 
increased body temperature. 
Alternatively, the reduced innate immunity response observed in PSE compared to CE could 
be linked to exposure to chemicals or biological agents that we have not measured in this study. 
In previous studies, peptidoglycan seem to be linked to adverse health effects post swine dust 
exposure [13, 23, 34, 104]. 
The cyclones possibly reduced the fine particles but in order to be even more efficient a few 
suggestions are made. The total air exchange of the cyclones are much less than the ordinary 
ventilation especially on hot days, yet the systems work against each other. During the colder 
seasons when the ventilation systems are less used to save indoor heat and energy, the cyclones 
are probably much more efficient. During this time of year, endotoxins levels in the air is also 
known to be higher than during warmer seasons. Additionally, to be able to turn on and off the 
cyclones when required would save energy and cost for the user and likely increase the 
effectiveness of the cyclones. 
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PAPER II 
The aim of this paper was to explore the in vivo effects of inhaled budesonide (single-blind, 
crossover design) on host innate immune response in swine farmers who are chronically 
exposed to organic dust and to further investigate the alveolar macrophages immune response 
after ex vivo co-stimulation with TLR-ligands and/or glucocorticosteroids. 
Swine farmers’ daily exposure to pro-inflammatory organic swine barn dust with its complex 
composition of feed, dander, faeces and endotoxin- and peptidoglycan releasing 
microorganisms induces respiratory symptoms such as cough and increased mucus production. 
This chronic exposure might contribute to the down regulation of innate immune 
responsiveness which previously has been shown in farmers. Swine farmers have an attenuated 
systemic inflammatory response to organic dust exposure in pig barns as compared to healthy 
non-farmers, including down-regulated TLR2 on blood monocytes [24], significantly 
decreased sTLR2 in sputum [81] and lack of IL-6 [24, 100] and sST2 increase in serum [81], 
after exposure to swine dust. The airway responses to pig barn dust exposure are altered in 
swine farmers compared with healthy non-farmers. Thus bronchial responsiveness and FEV1 
are not reduced to the same extent, exhaled nitric oxide does not increase, IL-6 release in 
sputum increase less and NAL cell count is not increased after swine barn exposure in the 
farmers when compared with healthy non-farmers [100, 101]. By treating the farmers with 
budesonide, the hypothesis was to induce their innate response. Bronchial epithelial cells have 
shown synergistically increased TLR2 expression upon co-stimulation of budesonide and TLR 
ligands in vitro [146]. Similar results were observed when stimulating alveolar macrophages 
from smokers with and without COPD with budesonide and TLR ligands [69].  
The recruited cohort of swine farmers included more men than women. Also the sub-set of 
farmers that underwent bronchial alveolar lavage showed heterogeneous characteristic in a 
similar way as the larger cohort. In the recruited cohort of swine farmers, all were working in 
confined swine buildings and had median accumulated exposure to swine farming environment 
of 20 years, spreading from 2 to 39 years, with a daily median exposure of 5 hours (Table 3). 
Even if no exposure measurement were performed it is clear, based on data in previous studies 
[15, 100, 105], that the farmers were exposed to organic dust via their occupation and work 
tasks that are required as swine farmer including cleaning of stables, feeding and weighing of 
swine. Possibly two of the farmers may have overestimated exposure as they since some years 
(after many years of conventional farming) produce pigs according to the Swedish rules for 
organic production (KRAV®). These rules require the swine to be outdoors for 4 months per 
year, which could possibly reduce the swine farmers’ exposure to a confined, indoor space 
during the summer months. Hoffman et al, 2005, showed that even former swine farmers with 
no current exposure to organic swine dust react similarly to active farmers upon renewed 
exposure [102]. Therefore, the impact on the biological responses of these two KRAV®-
farmers is possibly low and the results are likely not altered due to current production system. 
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Table 3. Characteristics of the participants. Data presented as median values and ranges except lung function 
data which are presented as mean (95% confidence interval). FEV1: Forced expiratory volume during 1 second. 
VC: Vital Capacity FVC: Forced vital capacity. Exposure is estimated work-related exposure to swine dust and 
swine house environment.  
 All farmers (n=15) Subset of farmers (n=7) 
Age (years) 38 (26-63) 34 (26-53) 
Length (cm) 178 (164-190) 175 (164-187) 
Weight (kg) 82 (57-113) 80 (57-113) 
Gender (f/m) 5/10 3 /4 
FEV1 (liter) 4.01 (3.48-4.54) 3.99 (3.67-4.34) 
FEV1 (% predicted value) 98.4 (90.8-106.0) 99.1 (90.2-108.7) 
VC (liter) 4.85 (4.24-5.46) 4.69 (4.22-5.20) 
VC (% predicted value) 92.1 (85.5-98.6) 91.1 (81.6-101.4) 
FVC (liter) 4.87 (4.27-5.48) 4.75 (4.28-5.26) 
FVC (% predicted value) 93.6 (86.8-100.4) 93.3 (83.0-104.4) 
Accumulated exposure (years) 20 (2-39) 12 (2-30) 
Weekly exposure (h/week) 19 (14-40) 25 (14-40) 
Daily exposure (h/day) 5 (2-8) 5 (2-8) 
Farm size (no of swine) 1050 (120-3500) 1125 (120-3500) 
 
In vivo  
The healthy farmers had normal lung functions which did not change after inhalation of 
budesonide or placebo. On the contrary, FEV1 was reduced in healthy non-farmers after 
exposure to organic swine dust [100]. In addition, the self-reported symptoms of the farmers 
did not change after the two treatments. In general the farmers reported weak (score 5-10 of 
100) cough, nose secretion, stuffed nose and fatigue.  
In sputum, sTLR2 and sCD14 are lower in farmers than in healthy controls [81]. In this study 
where we investigate the effects of budesonide in chronically exposed farmers, sputum cells 
were not altered during inhalations of budesonide or placebo and none of the soluble proteins 
measured (sTLR2 and sCD14) differed between the two treatments. Significant increase of 
sTLR2 was noted comparing before and budesonide treatment (p=0.002, n=15) (Table 4). Even 
if the concentrations of sTLR2 increased in sputum post budesonide treatment, swine farmers 
have still lower sTLR2 concentrations in sputum, than healthy control subjects; sTLR2 sputum 
concentrations: swine farmers<controls<smokers <COPD patients [81]. In this study, soluble 
ST2 was below detection limit.  
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Table 4. Soluble protein release of TLR2, CD14 and ST2 in sputum, serum and bronchoalveolar lavage fluid 
(BALF). Median and 25-75%. All data presented as pg/ml, except sCD14 in serum which is presented as ng/ml. 
  Baseline After budesonide After placebo 
 
p-values 
baseline-bud 
baseline-plac 
bud-placebo 
Sputum (n=15)     
(pg/ml) sTLR2 475 
(100-665) 
611  
(100-1047) 
445 (100-921) 0.002 
0.227 
0.135 
(pg/ml) sCD14 6475 
(1020-8508) 
5757 
(1730-8186) 
5015 
(3121-8665) 
0.281 
0.235 
0.570 
Serum (n=14)      
(pg/ml) sTLR2 1234 
(541-3365) 
1269 
(491-3156) 
1289 
(555-2970) 
0.103 
0.186 
0.900 
(ng/ml) sCD14 1124 
(1046-1257) 
1167  
(1039-1269) 
1124 
(1009-1318) 
0.510 
0.510 
0.272 
(pg/ml) sST2 63 (46-81) 63 (46-75) 57 (47-77) 0.148 
0.131 
0.470 
BALF (n=6)      
(pg/ml) sTLR2 304 
(242-487) 
347 
(243-394) 
 0.600 
(pg/ml) sCD14 3611  
(2763-3925) 
3895 
(3689-4184) 
 0.463 
 
Analysing blood (n=14) revealed that all blood cells (lymphocytes (p=0.041), basophils 
(p=0.048), eosinophils (p=0.004) and monocytes (p=0.041) except for neutrophils (p=0.074) 
increased in numbers after budesonide treatment compared to baseline but with no difference 
to placebo treatment. Also CD3+-cells increased (p=0.026) after budesonide compared to 
before with no difference to placebo, whereas CD8+ or CD4+ were not altered (Table 5). 
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Table 5. Concentration of leucocytes and the T-cell subset in peripheral blood of the swine farmers before and 
after budesonide and placebo treatment, expressed as number of cells ×106/L blood. (n=14). 
Cell type Before Budesonide Placebo 
 
p-value 
Bud-placebo 
Neutrophils 3142 
(2404-3771) 
3569 
(3012-5089) 
3487 
(3059-4400) 
0.433 
Monocytes 305 
(205-375) 
401 
(320-502) 
357 
(262-429) 
0.637 
Lymphocytes 1613 
(1114-1971) 
1797 
(1431-2202) 
1804 
(1414-2079) 
0.925 
Basophils 39  
(22-50) 
53 
(39-64) 
50  
(35-67) 
0.975 
Eosinophils 137 
(79-150) 
185 
(141-229) 
188 
(142-251) 
0.551 
CD3 1165 
(641-1406) 
1402 
(1129-1746) 
1331 
(1083-1512) 
0.975 
CD4 942 
(518-1252) 
1200 
(1074-1397) 
1166 
(819-1393) 
0.875 
CD8 351 
(258-480) 
431 
(342-539) 
471 
(264-511) 
0.875 
CD4/CD8 2.66 
(2.41-3.01) 
2.96 
(2.41-3.44) 
2.79 
(2.43-3.07) 
0.064 
 
Attenuated systemic inflammatory response in swine farmers have been shown in previous 
studies including down-regulation of TLR2 on blood monocytes [81]. Nevertheless, 
budesonide and placebo treatments in our study did not significantly change the expression of 
TLR2, TLR4 and CD14 expression on blood neutrophils and monocytes. Surface expression 
of CD14 on lymphocytes was below detection limit. Instead the TLR4 expression on 
lymphocytes doubled after budesonide treatment compared to both placebo and baseline 
(p=0.006 and 0.019 respectively, Figure 9).  
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Figure 9. Surface expression of TLR4 (%) on monocytes (diamonds), neutrophils (triangles) and lymphocytes 
(circles) in peripheral blood of swine farmers at baseline and after inhalation of budesonide and placebo. # p<0.05 
comparing budesonide treatment with before and placebo (n=14). 
 
When previously comparing farmers and healthy subjects, serum sCD14 and sST2 did not 
differ [81]. In the present study, treatment with budesonide or placebo did not significantly 
change the levels in serum of soluble TLR2, sCD14 and sST2 and CRP. The CRP median 
before treatment was 1.64 mg/L for the farmers, a level considered normal showing no signs 
of on-going systemic inflammation.  
The TLR2 expression could also be influenced by the proportion of different T lymphocytes 
including CD4+ T-helper (Th) cells and CD8
+ T-cytotoxic (Tc) cells. Sahlander et al showed 
that Th cells, especially IL-4 and IL-13 producing Th2 cells, are more abundant in farmers and 
smokers than in non-farming non-smokers [24]. These cytokines (IL-4 and IL-13) are also 
known to stimulate MUC5AC protein expression [147] which increases mucus production 
important for developing chronic bronchitis [148].  
Stimulated peripheral whole blood showed no significant differences of the percentage of Tc 
and Th cells between budesonide and placebo treatments. The proportion of IL-4 and IL-13 
expressing Tc cells decreased (p=0.041 and p=0.016 respectively, Figure 10) after budesonide 
treatment compare to before. Also placebo treatment significantly reduced the expression of 
IL-13 expressing Tc cells (p=0.013). Generally, the proportion of intracellular IL-13 and IL-4 
producing Tc2 cells is: control<farmers<<smokers [24, 147]. As the bud-treated swine farmers 
significantly decreased Tc2 cells producing intracellular IL-13 and IL-4, the treatment possibly 
shift the T-cell profile of the farmers to resemble more of the healthy controls. In smokers with 
COPD, IL-13 is generally higher than in healthy controls [84] and in vitro IL-13 induces 
mucin/mucus production [43]. Both these observations indicate that IL-13 can be of importance 
in the development of chronic bronchitis and the bud-driven reduction of IL-13 and IL-4 could 
be an essential factor for reducing the risk of developing chronic bronchitis.   
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Figure 10. Percentage of stimulated peripheral T-helper (Th) and T-cytotoxic (Tc) cells producing intracellular 
IL-13 and IL-4, before, after budesonide (bud), and after placebo (plac) treatment of swine farmers (n=14). 
Individual data and median (bold horizontal line) presented. # p<0.05 compared with before values. 
 
In BALF (n=7) AM mRNA of 10 genes expressed during inflammation and innate immune 
responses were investigated before and after budesonide treatment directly after isolation. 
Expression of GPx mRNA in AM significantly increased (p=0.043) after in vivo treatment of 
the swine farmers compared to before treatment whereas the other genes were not affected by 
the treatment. 
Ex vivo 
Three comparisons were made to explore the mRNA expression of 5 genes (TLR2, TLR4, 
CD14, IL-13 and CXCL8) in the ex vivo stimulated AM, before and after budesonide (Figure 
11):  
1. Influence of ex vivo budesonide stimulation; comparing AM with and without budesonide 
for same TLR ligand stimulation.  
2. Influence of ex vivo stimulation; stimulation compared to its own control (before and after 
respectively).  
3. Influence of in vivo budesonide treatment; identical stimulation, compared before and after 
in vivo treatment (n=4-7).  
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Ex vivo stimulation of budesonide increased the TLR2 mRNA expression before and after in 
vivo-treatment compared to non-stimulated control (both p=0.028). Expression of TLR2 
mRNA increased in AM after co-stimulation ex vivo with budesonide and peptidoglycan or 
LPS both before (PG; p=0.028, LPS; p=0.028) and after in vivo treatment (PG; p=0.028, LPS; 
p=0.046) compared to stimulation with LPS or peptidoglycan only. An increased expression 
was also observed when AM were co-stimulated ex vivo with budesonide and TNF-α 
(compared to TNF-α only), but only before in vivo-treatment (p=0.028, n=6). (Figure 11-1) 
When comparing the influence of in vivo treatment on AM TLR2 expression, no significant 
changes were observed. 
Ex vivo co-stimulation of budesonide and LPS decreased mRNA AM expression of CXCL8 
both before (p=0.028) and after (p=0.028) in vivo treatment compared to stimulation with LPS 
alone. Both before and after treatment, the ex vivo LPS stimulated AM showed significantly 
higher (5 and 16 times respectively) expression of CXCL8 mRNA than its own control 
(p=0.028 and p=0.028 respectively). Before in vivo treatment, ex vivo co-stimulation of AM 
with budesonide and TNF-α decreased mRNA CXCL8 expression compared to stimulating 
with TNF-α alone (p=0.028). After in vivo treatment, ex vivo stimulation with peptidoglycan 
significantly increased (doubled) the CXCL8 mRNA expression in AM from swine farmers 
compared to its own control (p=0.028). Co-stimulation of budesonide and peptidoglycan 
significantly decreased CXCL8 mRNA AM expression in farmers after in vivo treatment 
compared to stimulating with peptidoglycan alone (p=0.028). 
No clear in vivo effects of treatment on ex vivo CXCL8 mRNA expression were detected when 
comparing before and after in vivo treatment in AM (Figure 11-3). 
Ex vivo co-stimulation of bud and peptidoglycan significantly reduced CXCL8 release by AM 
of farmers before in vivo treatment compared to peptidoglycan alone (p=0.028, n=6). None of 
the other (co-)stimulations significantly altered the CXCL8 release. Farmers treated in vivo 
increased CXCL8 concentrations in ex vivo budesonide and peptidoglycan + budesonide 
stimulated AM compared to comparable stimulations of non-treated farmers (p=0.028 and 
0.046 respectively) (n=6). The in vivo treatment diminished the reduction of CXCL8 observed 
pre-treatment when ex vivo budesonide was added to peptidoglycan stimulated AM, described 
above (Figure 11-3).  
In commercially available normal human epithelial cells, the alveolar cell line A549 and AM 
from healthy controls, swine dust dose-dependently increases CXCL8 production [149] 
whereas budesonide causes dose-dependent inhibition of CXCL8 production in AM and 
increased TLR2 mRNA expression [150]. von Scheele at al, 2010 showed similar trends in 
TLR2 mRNA upregulation and CXCL8 reduction upon steroid and ligand stimulation [146]. 
In vitro co-stimulation of primary bronchial epithelial cells showed reduced CXCL8 mRNA 
expression and CXCL8 secretion where swine dust + budesonide gave a larger reduction than 
LPS + budesonide and also than the TLR ligand only. Generally this study also show a decrease 
in CXCL8 expression and release when being co-stimulated. A different trend could be 
observed in this study: the CXCL8 release especially and somewhat the mRNA expression of 
CXCL8 are increased after in vivo treatment compared to control. In two of the farmers, CXCL8 
increased in all ex vivo stimulated AM after in vivo treatment compared to before. This increase 
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could be explained by the increased mRNA expression of TLR2 that was revealed in the ex vivo 
experiment. The more available pattern recognition receptors the more pathogen-associated 
molecular patterns in organic dust could be bound, which could result in increased expression 
and release of CXCL8.  
It has been suggested that the formation of sTLR2 (shedding) is a cellular response to reduce 
over-stimulation of the cell surface receptor occurring in smokers with COPD [65]. In this 
study, release of sTLR2 from AM was below detection limit, except for two in vivo treated 
farmers where detectable concentrations of sTLR2 were measured in LPS and peptidoglycan 
± budesonide stimulated AM. As sputum sTLR2 significantly increased post budesonide in 
vivo treatment shedding activities is likely also in farmers. 
In vivo treatment and ex vivo stimulations of AM with budesonide or TLR ligands did not alter 
TLR4 mRNA expression, except in one case; after in vivo treatment, the stimulation of 
peptidoglycan significantly decreased (by half) the TLR4 expression compared to its own after 
treatment control (p=0.028, n=5) (Figure 11-1). 
Ex vivo stimulations with LPS, peptidoglycan or TNF-α did not alter CD14 mRNA expression 
in AM (Figure 11-2). 
Budesonide stimulation ex vivo of AM from in vivo treated farmers significantly lowered the 
expression of CD14 mRNA compared to its own control (p=0.028, n=6). Also, CD14 mRNA 
expression more than doubled in the control after in vivo treatment compared to before 
(p=0.043, n=5)(Figure 11-2). Increased TLR2 and CD14 mRNA expression implies a higher 
availability of receptors for ligands, leading to a pro-inflammatory response including the 
increased concentrations of CXCL8 in AM. 
Concentrations of secretion of sCD14 and IL-13 in AM were below detection limits (62.5 and 
93.8 pg/ml respectively) (n=6).  
Before treatment, ex vivo co-stimulation of budesonide and TNF-α significantly decreased the 
mRNA expression of IL13 compared to TNF-α alone (p=0.028, n=6)(Figure 11-2).  
In vivo effects of budesonide were observed for IL13 mRNA expression. In the non-stimulated 
controls, the mRNA expression of IL13 significantly increased in in vivo treated farmers 
compared to before treatment (p=0.043). After in vivo treatment, IL13 mRNA expression in 
AM increased when being co-stimulated with budesonide and peptidoglycan compared to the 
same stimulation before in vivo treatment (p=0.043, n=5)(Figure 11-2).  
In this study, we used two different models to analyse mRNA expression in AM. One where 
the AM were directly prepared from BALF and the other after over-night starvation without 
added serum to the culture media followed by a six hours incubation with different stimuli. 
Analysing 10 genes using direct preparation only one (GPx) was significantly increased after 
in vivo treatment. After starvation, five genes were examined and IL-13 and CD14 were 
significantly increased after budesonide in vivo treatment of farmers. Over-night starvation of 
AM seems to be required to synchronise cells to achieve measureable non-confounded levels 
of mRNA.  
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Figure 11-1. Expression of TLR2 and TLR4 mRNA from AM isolated from swine farmers’ bronchoalveolar 
lavage fluid, before (a) and after (b) in vivo budesonide treatment, incubated for 6 hours in control medium, LPS 
(lipopolysaccharide), PG (peptidoglycan) or TNF-α with or without budesonide (B) including medians (bold line). 
# p<0.05, stimulated cells; with B compared to same stimulation without B. § p<0.05 stimulated cells; stimulation 
without B compared to its own control (before or after) *p<0.05, identical stimulation, compared before and after 
in vivo treatment (n=4-7).  
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Figure 11-2. Expression of CD14 and IL13 mRNA from AM isolated from swine farmers’ bronchoalveolar 
lavage fluid, before (a) and after (b) in vivo budesonide treatment, incubated for 6 hours in control medium, LPS 
(lipopolysaccharide), PG (peptidoglycan) or TNF-α with or without budesonide (B) including medians (bold line). 
# p<0.05, stimulated cells; with B compared to same stimulation without B. § p<0.05 stimulated cells; stimulation 
without B compared to its own control (before or after) *p<0.05, identical stimulation, compared before and after 
in vivo treatment (n=4-7).  
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Figure 11-3. Expression of CXCL8 mRNA and release of CXCL8 from AM isolated from swine farmers’ 
bronchoalveolar lavage fluid, before (a) and after (b) in vivo budesonide treatment, incubated for 6 hours in control 
medium, LPS (lipopolysaccharide), PG (peptidoglycan) or TNF-α with or without budesonide (B) including 
medians (bold line). # p<0.05, stimulated cells; with B compared to same stimulation without B. § p<0.05 
stimulated cells; stimulation without B compared to its own control (before or after) *p<0.05, identical stimulation, 
compared before and after in vivo treatment (n=4-7).  
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Correlations 
To elucidate the possible interactions between some of the measure endpoints, correlations 
analysis were made (Figure 12). Some obvious correlation clusters of lung function and blood 
cell distribution were found but also some more unforeseen.  
When investigating lung function and number of blood cells, it is clear that the more impaired 
lung function (VC, FEV1 and FVC) the more leucocytes in peripheral blood (lymphocytes, 
neutrophils and eosinophils, p≤0.03). When adjusting lung function for height and age, all lung 
function parameters were positively correlated to both sCD14 and sTLR2 in BALF (p≤ 0.005). 
Soluble TLR2 in BALF correlated with sCD14 in BALF (p=0.005), but also sST2 in serum 
(p=0.005). Whereas sST2 in serum correlated to sCD14 in BALF (p=0.04) and to both TLR2 
and CD14 on blood monocytes (p=0.05 and 0.009). All correlations were positive. The co-
variation between serum sST2 and sTLR and sCD14 in BALF have never previously been 
reported. These correlations are observed even if there are no significant treatment-related 
changes for these endpoints. It suggests that less invasive methods like measuring sST2 in 
blood could be a relevant and a useful biomarker for measuring host innate defense instead of 
investigating the more known soluble proteins sTLR2 and sCD14 in bronchoalveolar lavage. 
TLR2 on blood monocytes were positively correlated to CD14 expression on both monocytes 
and neutrophils (p=0.0001 and 0.030 respectively), whereas negatively correlated to TLR2 and 
TLR4 on neutrophils (p=0.0005 and 0.002). TLR2 on neutrophils were positively correlated 
with TLR4 expression on neutrophils and lymphocytes (p= 0.02 and 0.02) but negatively 
correlated to CD14 expression on monocytes (p=0.01). TLR4 expression on neutrophils were 
positively correlated to TLR4 on lymphocytes (p=6.9×10-5). TLR4 expression on neutrophils 
was also negatively correlated to CD14 expression on monocytes and neutrophils (p=0.04 and 
0.03). Interestingly, Sahlander el at, 2012 found that farmer TLR4 on blood neutrophils 
negatively correlated to soluble CD14 in sputum [81].  
Correlations on directly prepared AM mRNA showed that TLR2 correlated to TIMP (p=0.02), 
SLPI to SOD3 and GPx (p=0.05 and 0.02 respectively), IL13 to SOD3 and LL37 (p=0.05) and 
0.02 respectively) and SOD3 to LL37 (p=0.04). GPx also correlated to TLR2 expression on 
blood neutrophils and lymphocytes. All were positively correlated. 
LeVan et al, 2005 showed that the CD14/-159 and CD14/-1619 loci positively associated with 
wheezing in farmers [151]. We also found a correlation between wheezing and by mRNA 
CD14 expression on directly prepared AM (p=0.034). mRNA expression of CD14 in AM was 
positively correlated to sCD14 in serum (p=0.01) whereas sCD14 in BALF correlated to 
shortness of breath (p=0.042). 
mRNA expression of TLR2 in AM was negatively correlated to sTLR2 in serum (p=0.01) and 
TLR4 in AM was negatively correlated to sTLR2 in sputum (p=0.03). 
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Figure 12. Heat-map of Spearman rank correlations of data-points from non-treated swine farmers. Blue square; 
negative correlation (ρ=-0.50- -1.00), p<0.05 Red square; positive correlation (ρ=0.50-1.00), p<0.05. 
 
As in all complex study models there are drawbacks with the systems used. Here, the short 
two-week treatment period, the limited number of available swine farmers in commuting 
distance to Stockholm area combined with the farmers phenotypic diversity could likely have 
influenced the results of the study. Polymorphism of the farmers’ TLR and glucocorticoid 
receptors have not been investigated in this study. Even if performing a crossover design study, 
which generally reduces the between-subject variability and increases power by limiting non-
treatment related factors, the above limitation cannot be fully overcome. The healthy worker 
effect is another possible limitation, as farmers with pulmonary problems may have stopped 
working at the swine farm.  
In conclusion, we found in this crossover study that swine farmers, who are chronically exposed 
to organic dust who inhale glucocorticosteroid for two weeks increase the release of soluble 
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TLR2 in the airways and the number of circulating leucocytes. The TLR4 expression on 
lymphocytes increased and the cytotoxic T-cell surface expression of IL-13 and IL-4 decreased 
after Bud-treatment. Additionally, mRNA expression in AM from a smaller subset of farmers 
increased TLR2 and decreased CXCL8 after ex vivo co-stimulation with 
LPS/peptidoglycan/TNF-α and Bud. The mRNA expression of CD14, IL-13 and GPx in AM 
increased after the in vivo Bud-treatment of swine farmers. 
These in vivo findings confirm recent in vitro results using epithelial cells and macrophages 
from healthy donors; down-regulated TLR2 in swine farmers’ immune cells increase after 
short-term treatment with ICS. Our findings indicate that inhalation of a glucocorticosteroid 
strengthens immune defense pathways in subjects with occupational chronic exposure to 
organic dust. This may have implications for understanding the steroid effect in the treatment 
of conditions such as chronic bronchitis and COPD that are characterized by microbial 
colonisation in airway conditions.               
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PAPER III 
The aim of this paper was to first develop an advanced three-dimensional in vitro system 
resembling a bronchial airway mucosa and second to combine this model with a complex 
exposure technique to mimic the in vivo scenario.  
Human primary bronchial epithelial cells (PBEC) formed the basis of the model in the insert 
together with fibroblast MRC-5 cell line grown under the insert membrane facing the well. 
Initially the cells were grown in collagen [152, 153] but as the models shrunk, the exposure 
dose of the models would have been difficult to calculate. The co-culture of these cells were 
maintained under air-liquid interphase where medium was only supplied in the well under the 
insert. Once a stable model was developed, research to establish a chronic bronchitis-like 
models was initiated. By adding IL-13 at the start of air-lifting, the modified mucus producing 
model was developed. 
Palladium is a rare metal found in the upper crust of earth and is commonly used in nanoform 
in catalytic converters in the automobile industry. Palladium nanoparticles is present in air as 
airborne automotive pollution caused by abrasion of catalyst material of the car exhaust system. 
Previously, toxicity of palladium particles was assessed in vitro, using PBEC and alveolar cell 
line A549 and cultured and exposed under submerged conditions [130]. Using the newly 
developed XposeALI®/PreciseInhale, the new bronchial models could be exposed to 
aerosolized nano-sized palladium particles. 
Beating of ciliated cells including the typical microtubules structure of the cilia, differentiation 
into goblet cells and club cells are important characteristics of the airway mucosa. All these 
requirements were important when establishing a mucosa model. For chronic bronchitis, the 
hyper/metaplasia of mucus producing cells was crucial.  
Evaluating the models using different staining techniques, it was clear that all important 
features for a bronchial mucosa were achieved. Already in light microscope beating cilia was 
seen. H&E staining revealed the differentiation into basal cells, club cells, mucus producing 
cells and ciliated cells (Figure 13A). Immunofluorescent staining and confocal microscopy 
confirmed cilia (in green) and expression of MUC5AC (red) on goblet cells shown in Figure 
13B. To confirm cilia containing axonemes with two central singlet and nine outer doublet 
microtubules, SEM (Figure 13C) and TEM (Figure 13D and E) were required. Figure 13E also 
confirms the presence of electro-dense cytoplasm typical for mucus producing cells.  
To assess the differentiation of the cells, mRNA expression of specific cell markers was studies 
over a three-week period. Only FOXJ1 mRNA expression, a ciliated cell marker, significantly 
increased over time when being air-lifted as detected by RT-PCR (Figure 14A). MUC5AC, 
club cells protein and KRT5 (basal cell marker) did not alter mRNA expression being airlifted 
for three weeks (Figure 14B, C and D). 
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Figure 13. Morphological characterization of 3D model [45].  
A: Light microscope analysis of hematoxylin and eosin (H&E) staining of paraffin embedded cross section of 2   
weeks ALI model; Bar scale: 100 μm. Higher magnification showed cilia and mucus; Bar scale: 100 μm.  
B: Confocal microscope analysis of immunofluorescence staining of ciliated cell marker anti-acetylated alpha 
tubulin antibody (green florescence), mucus producing cell marker anti-MUC5AC antibody (red florescence) in 2 
weeks ALI model; cell nuclei stained with DAPI (blue florescence). Bar scale: 20 μm.  
C: Scanning electron microscope analysis of 2 weeks ALI model, mature cilia present; Bar scale: 1 μm.  
D: Transmission electron microscope analysis of 2 weeks ALI model, ciliated cell surface was scattered with 
elongated cilia; Bar scale: 5 μm. Higher magnification showed cilia displaying 9+2 axoneme formation, tight 
junction (black arrow) and desmosome (white arrow); Bar scale: 2 μm.  
E: Transmission electron microscope analysis of 2 weeks ALI model, mucus cell present with electron-dense 
cytoplasm containing electron-lucent granules; Bar scale: 2 μm. 
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Figure 14. mRNA expression of different cell type markers in 3D models. Expression of ciliated cell marker 
FOXJ1 (A), mucus producing cell marker MUC5AC (B), club cell marker Club cell protein (C) and basal cell 
marker KRT5 (D) mRNA in normal models after culturing at ALI for 1, 2 and 3 weeks (N = 9). Data presented as 
median and 25th -75th percentiles; &: P<0.05 VS FOXJ1 mRNA expression in 1 week culturing at ALI [45]. 
      
 
 
Fig 15. Effects of IL-13 stimulation on 3D models. A: Fold change of MUC5ACmRNA expression in ALI 
models treated without (blank) and with 1 ng/ml (grey) and 10 ng/ml (black) IL-13 for 1, 2 and 3 weeks (N = 9); 
Data presented as median and 25th -75th percentiles. B: Periodic acid—Schiff (PAS) staining of paraffin 
embedded cross section of ALI models treated without and with 1 ng/ml and 10 ng/ml IL-13 for 2 weeks visualized 
by light microscope; Bar scale: 100 μm. [45] 
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When treating the model with 10 ng/ml IL-13, almost all cells differentiated into mucus 
producing cells as shown by PAS staining in Figure 15. Instead, a lower concentration of 1 
mg/ml IL-13 was chosen to modify the mucosa model into a chronic bronchitis-like model. 
To validate the viability of the models trypan blue showed that >95% viable cells and the 
apoptotic rate 1-30%. TEER showed no difference in integrity of the barriers and tight junctions 
between the normal and the chronic bronchitis-like model. The models were kept viable for 3-
4 weeks after being air-lifted. The first sign of model function loss is the cilia that reduce in 
number as well in structure, soon becoming bud-like. 
Second step was to introduce the palladium particles and the aerosol exposure system. X-ray 
diffraction and EDS analysis of the palladium particles showed high purity. Palladium in 
ethanol solution [130]) was vacuum dried and yet the particles agglomerated during this 
process, they easily aerosolized in small particles (6-10 nm) when shot in PreciseInhaleTM 
(Figure 16).  
                            
Figure 16. Size distribution of aerosolized Pd nanoparticles. Size 6–10 nm with a distinct maximum at 8 nm 
[45]. 
 
Using PreciseInhaleTM and XposeALI® for palladium exposure showed evenly distributed 
particles throughout the insert and the cells. Most of the particles stayed on top of the cells 
whereas some internalized in the cells and longer incubation time seemed not to influence this 
finding. After 24 hours post-exposure the mucociliary transport of the models seem to have 
relocalized the palladium to one corner of the insert (Figure 17). This is very different than 
dispered palladium nanaoparticles in submergely cultivated PBEC [130]. Within two hours, 
PBEC had taken up the majority of palladium particles now found in membrane-bound 
vesicles, likley due to active uptake (endocytosis) [154, 155]. Not only are the exposure settings 
very different from using ALI conditions and aersol exposure, but also is it likely that the 
nanoparticles in media is surronded by a corona of biomolecules that could affetcs the toxicity 
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of the particle and modulating the particle recognition by the cell. [156]. As the mucos surfacing 
the cilia in the models likely protects the cells from actual exposure to nanoparticles, the in 
vitro 3D model much better represent the real life situation. 
 
 
 
 
 
Figure 17.  Uptake and clearance of palladium nanoparticles in vitro. A: The internalization of palladium 
nanoparticles in bronchial mucosa model, incubated 24 hours post-exposure. Most palladium nanoparticles are 
localized on the cell surface (black arrow) and few nanoparticles are localized inside the cells (white arrow). Bar 
scale: 2 μm. Mucociliary clearance: B: Even distribution of palladium nano-particles (high dose: 650 ng/cm2).  C: 
Relocalization of palladium nanoparticle. Accumulated in one spot within 24 hours, indicating mucociliary 
clearance. [45] 
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After exposure, viability was assessed (as above) and exposure did not affect the viability in 
any of the models. 
Wilkinson et al, 2011 [130] demonstrated that dispersed palladium nanoparticles in submergely 
cultured PBEC increased CXCL8-release to the culture media. In our study, the release of 
CXCL8, MMP-9 and club cells protein in apical and basal medium of both models (+/- IL-13) 
were measured at 8 and 24 hours post palladium aerosol exposure (control, 250, 400 and 650 
ng/cm2). The concentration of club cell protein was not affected by neither  IL-13 nor palladium 
exposure. Neither the release of MMP-9, important for remodeling of lung tissue and mainly 
secreted by cells upon inflammatory stimulation [85, 157], was altered by IL-13 stimulation or 
palladium nanoparticle aerosol exposure. Much higher concentrations of MMP-9 was found in 
apical media than in basal media, even if the apical media was only collected for 15 minutes 
by lavage whereas the basal media contained the cumulative release of MMP-9 over 8 or 24 
hours. For CXCL8, this apical/basal media difference was not observed (Figure 18). Upon 
palladium exposure, CXCL8 release was higher (significantly after 24 hours and similar trend 
after 8 hours post-exposure) in the chronic bronchitis-like models than in the normal models. 
If the smaller CXCL8 (8.4 kDa) was mainly produced on the apical side, it could more easily 
penetrate the confluent layer of differentiated bronchial cells and the membrane pores than the 
slighter larger MMP (92 kDa). The pores are likely not the limiting factor as they are sized 400 
nm in diameter. The differences in molecular weight of the proteins is less obvious when 
protein size is estimated as a10 kDa protein is about 3 nm in diameter and 100 kDa protein is 
about 6 nm [158]. This suggests that MMP-9 is possibly secreted by epithelial cells, whereas 
CXCL8 is probably produced by both epithelial and fibroblasts. 
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Fig 18. Release of CXCL8 (IL-8) after palladium nanoparticle exposure using XposeALI®. 
Post-exposure concentrations (8 or 24 hours) of CXCL8 in basal (A and B) and apical (C and D) media of normal 
or chronic bronchitis-like (1 ng/ml IL-13) models (n = 9) models exposed to palladium nanoparticles (sham: 
normal air and clean system; low: 250 ng/cm2; med: 400 ng/cm2; high: 650 ng/cm2). Median presented with 25th -
75th percentiles; #: p<0.05 vs sham exposure; *, **: p<0.05, 0.01 vs normal model. [45] 
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GENERAL DISCUSSION 
Todays’ global consumption of meat and mainly pork have led to intense animal production 
with high through-put in large scale [31, 159]. According to statistics from Swedish Board of 
Agriculture, the Swedish meat consumption doubled from 1960 till today (from almost 25 kg 
to 50 kg per person and year). In the last 10 years, there has been a slight decrease probably 
due to today’s focus on environmental concerns linked to meat production. 
Swine intended for meat production live their whole life (about 0.5 year) inside an enclosed 
swine building, while farmer can be found working in this environment 40 hours per week for 
more than 40 years. Exposure to organic swine dust is an important health risk to consider for 
both the farmers working in the barns as well as housed swine. Organic dust is not exclusive to 
swine farming but is also present in other agricultural settings (poultry, grain) as well as the 
textile (cotton) and the forest (wood) industries. The organic dust contains pro-inflammatory 
bacterial fragments like endotoxin and peptidoglycan. Inhaling particles and these constituents 
lead to an increased risk of reduced lung function [160, 161] and developing respiratory 
diseases like chronic bronchitis and COPD [162-164].  
One of the basic principle of risk management in occupational hygiene is the hierarchy of 
controls including elimination, substitution, engineering and administrative controls and lastly 
the use of personal protective equipment [165]. The concentration of organic dust can be high 
in conventional swine production but few studies have investigated if the dust levels can be 
reduced by organic production. In 2007, airborne concentrations and composition of particles 
was compared in conventional and organic swine production [166]. The German study 
included two organic farms complying with European directive on organic production of 
agricultural products (EEC 2092/91, 2003) where the main difference is the requirement of 
using bedding material. Here, no difference in indoor organic dust and endotoxin levels was 
shown. Yet it is unclear if or how long these swine were outdoors. Swedish animal production 
conditions for both conventional and organic swine are in many areas more stringent than the 
rest of the Europe and the world. Swedish conventional production is more protective of the 
swine and the environment including less use of antibiotics, bedding requirement and minimum 
space allowance per swine. Swedish organic swine, according to KRAV®, need to be outdoors 
at least 4 months per year. This suggests that organic production causes less exposure to organic 
swine dust of both swine and workers but studies show that this production system could 
introduce other occupational risks [167]. 
In this thesis, the first paper focused on the use of engineering controls to reduce the exposure 
to the highly potent organic dust by assessing the efficiency of cyclones to reduce dust and fine 
particles in swine barn air and the health impact of exposure volunteers. The cyclones reduced 
the fine particles in the air and both local and systemic adverse effects in the volunteers 
diminished.  
The study was performed during the summer and both out-door temperature and humidity 
fluctuated during the study period, although it was performed within a month in early summer. 
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Generally these parameters affect particle formation and duration in air and it is well-known 
that particle concentration in swine buildings are higher during winter than in summer [31, 
141]. During summer the ventilation is high to maintain a good climate (temperature) for the 
swine which are very sensitive to heat [168]. The ventilation reduces the particles in the air by 
high air-exchange and hot pigs are very inactivity which also reduces the particle numbers in 
air. The installed cyclones ran during these conditions which were unfavourable to the study in 
order to understand their actual efficiency and effectiveness. To better assess this, future studies 
should be performed during winter when less ventilation and higher particle concentrations are 
likely. Combined with good house-keeping and cleaning routines including high-pressure 
hosing between the pig batches the cyclones could possibly be a viable and effective measure 
to reduce exposure to polluted air. 
Reducing exposure of swine dust is important not only to reduce immunological alteration of 
the farmers. Over the last years, swine dust containing live-stock methicillin-resistant 
Staphylococcus aureus (LA-MRSA) have highly increased [169, 170]. Notably in Denmark, 
the prevalence of infected farms has gone from 16% in 2010 to 88% in 2016. The presence of 
antibiotic resistance is widespread in Europe and globally and both country and production 
type seem to be important factors for the occurrence [171, 172]. Infections of LA-MRSA 
impact not only swine, but also the farmers, the farmer’s families and swine farm veterinarians. 
The bacterial colonisation in the airways of swine farmers might be important for the 
development of swine dust tolerance and is associated with increased frequency of COPD 
exacerbations [173] 
The tolerance to organic swine dust appears in current and former farmers [101, 102, 174]. The 
tolerance development itself might not be beneficial to the farmers in the long-term perspective 
if it is related to their known increased risk of developing chronic bronchitis and COPS [160]. 
Still there is lack of understanding of the mechanism behind the tolerance [175]. To reduce the 
risk of tolerance development and immune system alteration, many methods to reduce dust 
exposure have been tried over the years, including robot cleaning and oil spraying. Up-
regulating the host response in farmers has to date never been tried. This is why we in paper II 
explored the influence of budesonide treatment of current healthy swine farmers. The crossover 
study with budesonide and placebo resulted in increased sTLR2 in sputum and TLR4 on 
lymphocytes and decreased Tc cells producing IL-4 and IL-13 after budesonide treatment. Also, 
CD14, IL-13 and GPx mRNA expression in alveolar macrophages increased after the in vivo 
steroid treatment. In all, the results indicate that short-term (2 weeks) treatment with inhaled 
budesonide up-regulates the down-regulated immune defense observed in chronically exposed 
swine farmers. However, it is unclear if long-term treatment would have the same effects or if 
there are any unwanted side effects. Short-term the steroid treatment boosted the immune 
system of the farmers, which could likely be sustained by prolonged treatment. Yet, it is unclear 
if this would be beneficial for the farmers long-term. The tolerance to swine dust is the host’s 
adaptation to the environment and such treatment and alteration of the immune system makes 
the farmer’s immune system resemble that of healthy volunteers who develop ODTS once 
exposed to the swine farm environment. It is obvious that treating farmers so that they 
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subsequently develop ODTS would not be a desired outcome. Long-term ICS is used for 
asthma- and COPD treatment [176]. Reported adverse effects from long-term use include 
growth suppression in children and reduced bone density in elderly. Since farmers do not 
belong to these patient groups it is difficult to speculate on the possible adverse long-term 
effects.  
In both paper I and II we used human in vivo experiments to assess the short- and long-term 
influence of the swine dust. Instead of using a human model, swine model could be a useful 
alternative since the animal is anatomically and physiologically similar to humans [177]. It has 
even been suggested that the swine themselves could be used for assessing the risk of 
occupational hazard of farm workers [159]. 
Instead of swine as an alternative to human exposure experiments, we used human (primary) 
cells in paper III. By combining a species-relevant organotypic model with actual air pollutants 
we created an in vitro model resembling an in vivo situation. Throughout the development there 
has been a lot of “learning by doing” and thereby continuous technical and biological/cellular 
improvements including choice of media and cells, cell co-culture settings and culture 
techniques. This in vitro journey has just started and there are still many possibilities for further 
developments. For instance, long-term and/or chronic experiments and possibly even alveolar 
models could be developed for even further refined and accurate responses to ultrafine and 
ambient particles in air. 
Additionally, the existing bronchial model could be altered and explored in many ways e.g 
origin of epithelial donors, new unstudied substances or mixtures or perhaps even new co-
culture combinations. To study the epithelial difference from different groups of donors one 
example could be groups of different alcohol consumption including farmers. Alcohol 
consumption is known to increase risk of bronchitis and in vitro impair TLR2 on airway 
epithelial cells and their mucociliary clearance [178]. Farmers are in some areas more prone to 
drink more alcohol than the average population whereas in Sweden farmers drink less alcohol 
than average [179]. Swine dust is already known to reduce TLR2 in farmers and it could be 
further investigated if this is synergistically reduced in farmers with high alcohol and/or 
cigarette consumption. 
In paper III we found that palladium particles was moved into one spot by the beating cilia. 
Futrure studies could investigate if other substances interact with the model differently. 
Previously, cilia beating frequency was reduced in vitro using bovine ciliated cells exposed to 
dissolved organic swine dust [180]. Would swine dust exposure change the cilia beating 
frequency or direction if using the 3D model?  
Primary macrophages have to date been difficult to combine with 3D model. If this would be 
possible in the future, the interesting results of Ji et al, 2018 regarding macrophage anti-
inflammatory M2 polarization after exposure to diesel exhaust particles could be further 
explored [49]. Alveolar macrophages from farmers expressed more anti-inflammatory IL13 
upon budesonide treatment than before treatment. Further research could investigate if freshly 
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prepared macrophages from different human populations could be used in the 3D model and if 
other ultrafine and ambient particles also would result in M2 polarisation. 
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CONCLUSIONS 
Paper I:  
 Organic dust including endotoxins is present in swine building environment. 
 Installing particle separators (cyclones) in swine buildings reduced mainly the fine (0.3-0.5 
µm) particles. 
 The adverse acute symptoms including headache and increased body temperature in 
healthy volunteers exposed to organic swine dust were reduced in the particle separated 
swine building environment compared to the conventional swine building environment. 
 The particles separated environment reduced the upper respiratory tract pro-inflammatory 
responses (IL-6 and CXCL8) in healhy volunteers compared to the conventional swine 
building. 
 The effectivness of cyclones could possible be improved if used when particles numbers 
are high(er) i.e. during winter months. 
Paper II: 
 Swine farmers chronically exposed to organic dust who inhale glucocorticosteroid for two 
weeks increased the release of soluble TLR2 in the airways. 
 Systemic effects after budesonide treatment in the farmers include increased number of 
circulating leucocytes and TLR4 expression on lymphocytes, and decreased cytotoxic T-
cell production of IL-13 and IL-4. 
 In alveolar macrophages from a smaller subset of farmers mRNA TLR2 expression 
increased and CXCL8 decreased after ex vivo co-stimulation with LPS/peptidoglycan/TNF-
α and budesonide. 
 The mRNA expression of CD14, IL-13 and GPx in alveolar macrophages increased after 
the in vivo steroid treatment of swine farmers. 
 The study showed that inhalation of a glucocorticosteroid strengthens the immune defence 
pathways in subjects with occupational chronic exposure to organic dust. 
Paper III: 
 We established a viable and robust in vitro bronchial mucosa co-culture model using human 
primary bronchial cell and fibroblast cell line showing in vivo cell characteristics. 
 We modulated the model by stimulation with IL-13 to allow differentiation into a more 
chronic bronchitis-like model.  
 These models were successfully combined with the advanced aerosol exposure system 
PreciseInhaleTM and the in vitro module XposeALI® and exposed to palladium 
nanoparticles. 
 Palladium nanoparticles induced inflammatory responses in the 3D model. 
 The 3D model could be further refined and developed for future use in replacing acute and 
chronic animal tests studying local effects.  
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POPULÄRVETENSKAPLIG SAMMANFATTNING 
Sällan andas vi ren luft. Är den inte naturligt förorenad med pollen, sand, jord eller salt så har 
människan förorenat den med avgaser i form av gaser och partiklar från trafik och industri. Ett 
av Sverige miljömål ’Frisk luft’ definieras som ”Luften ska vara så ren att människors hälsa 
samt djur, växter och kulturvärden inte skadas.” 
Hur vet vi att dessa värden inte skadas? För att förstå det krävs kunskap om ämnens inneboende 
egenskaper och hur de påverkar sin omgivning. 
Många arbetsplatser har förorenad luft och speciellt utsatta är svinskötare. Damm som bildas i 
svinstallar i samband med grishållning innehåller många olika beståndsdelar, bland annat rester 
från foder, hud, urin och avföring. Detta organiska svindamm är rikt på mikro-organismer 
inklusive bakterier och kan påverka både svinens och svinskötarnas hälsa. Någonting i dammet 
gör att kroppens immunförsvar påverkas och hur kroppen reagerar beror på hur ofta du 
exponeras för svindammet. En person som aldrig eller sällan vistats i svinhus kommer att inom 
24 timmar efter påbörjad exponering få influensaliknande symptom som går över efter ett par 
dygn. En svinskötare som dagligen arbetar in svinhusmiljö har istället utvecklat tolerans mot 
miljön genom ett förändrat immunförsvar och får avsevärt mildare symptom efter 
svinhusvistelse. Trots detta är hosta vanligt bland svinskötare och de har högre risk att utveckla 
kronisk bronkit och kronisk obstruktiv lungsjukdom (KOL) än övriga befolkningen.  
Denna avhandling syftar till att öka kunskapen kring hur man med en teknisk uppfinning kan 
minska exponering för organisk damm i svinhus för att förbättra svinskötares hälsa, om ett 
välanvänt läkemedel kan påverka förändringarna på immunförsvaret som uppkommer hos 
svinbönder efter långvarigt arbete i svinstallar samt ta fram en ny förfinad laboratoriemetod för 
att undersöka små luftburna partiklars toxicitet vilket skulle undvika framtida försök på djur 
och människa. 
I det första delarbetet installerades cykloner i ett av två identiska svinhus, i vilka bägge sedan 
friska, frivilliga vistades under 3 timmar. Före och efter svinhusbesöken, som skedde med 
några veckors mellanrum, undersöktes försökspersonerna. De fyllde i en symptomenkät samt 
genomförde spirometri, nässköljning och blodprovstagning. Dessutom karakteriserades 
exponeringen och partiklarna i svinhusluften. Cyklonerna resulterade i färre antal partiklar, 
speciellt de små i storleken 0,3-0,5 µm jämfört med det konventionella stallet utan installerade 
cykloner. Efter att försökspersonerna vistats i stallet med installerade cykloner upplevdes 
mindre huvudvärk och deras kroppstemperatur ökade inte lika mycket som efter att de vistats 
i det konventionella stallet. Försökspersonernas immunförsvar i både blod och nässköljvätska 
reagerade olika beroende på vilket svinhus de exponerats för. Generellt ökade antalet 
”bakteriereceptorer” (TLR2 och TLR4) på blodmonocyter (en typ av vita blodkroppar som är 
viktiga för det medfödda immunförsvaret) och små signalmolekyler, med uppgift att aktivera 
inflammation, i nässköljvätska. 
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I det andra delarbetet rekryterades 15 friska, icke-rökande svinskötare som under två veckor 
antingen behandlades med inhalationssteroid (budesonid, en vanlig astmamedicin) eller 
placebo samtidigt som de fortsatte arbeta i svinhus och därmed exponerades för svinhusdamm. 
Före och efter behandling fick svinskötarna fylla i symptomenkät och genomgå 
blodprovstagning, spirometri samt inducera sputum (en metod för att hosta upp slem från nedre 
luftvägarna). Efter budesonid-behandling stimulerades svinskötarnas immunförsvar genom att 
antalet vita blodkroppar och ”bakteriereceptorerna” (TLR4 på blodlymfocyter och lösliga 
TLR2 i slemmet från nedre luftvägarna) ökade samt anti-inflammatoriska signalmolekyler i 
blodets T-lymfocyter minskade.  
Nästan hälften av svinskötarna genomgick mer djuplodande undersökningar före och efter 
budesonid-behandling i form av bronkoalveolärt lavage vilket utfördes under bedövning på 
sjukhus. Genom att skölja lungorna med koksalt kan celler (alveolära makrofager) samlas in 
för vidare stimulering utanför kroppen, så kallade ex vivo-försök. I laboratorium utsätts 
makrofagerna med olika inflammationshöjande stimuli med eller utan budesonid. Stimulering 
med budesonid påvisar att svinböndernas immunförsvar, som annars är neddreglerat på grund 
av kronisk exponering i svinhus, nu förbättras till att mer likna nivåer som återfinns hos 
befolkningen i övrigt. Bland annat ökar tillverkningen av ”bakteriereceptorn” TLR2 i 
makrofagerna. 
I det tredje delarbetet tillverkade vi en tredimensionell cellmodell där vi sam-odlade olika typer 
av human lungceller för att efterlikna mänsklig lungvävnad. Det vanliga vid cellodling är att 
odla celler i cellmedium. Här ville vi simulera lungvävnad där cellerna utsätts för omgivande 
luft vid inandning. Cellmodellen bestod av bindvävsceller och bronkiella epitelceller som, 
under odling med luft på ovansidan och cellmedia endast under cellerna, ombildades till olika 
typer av celler som normalt återfinns i luftrören: flimmerhårsceller, slemutsöndrande 
bägarceller och stamceller som klubbceller och basalceller. Vi kunde också stimulera 
slemtillverkning och på så vis efterlikna en lungmodell med kronisk bronkit. För att undersöka 
hur lungmodellerna reagerade på luftföroreningar (i detta fall palladium-nanopartiklar, 
förekommande i avgaser från motorfordon) kombinerades modellen med ett nytt 
exponeringssystem: PreciseInhaleTM & XposeALI®. Denna kombination gör att man kan 
exponera celler för partiklar i luft, i stället för som brukligt med partiklar lösta i cellmedia. 
Denna dimension gör att inte bara cellmodellen efterliknar lungvävnad men också 
exponeringen liknar den som sker i en lunga via luft-blodbarriären.  
Denna avhandling visar att det går att minska svindammspåverkan hos människa genom att 
antingen minska exponeringen genom tekniska åtgärder eller med steroidbehandling. Våra 
framtagna humana lungmodeller och exponeringssystem kan tillsammans användas för att 
vidare studera toxiska och immunologiska effekter av partiklar i luft exempelvis i svinhus.  
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